<!DOCTYPE html> <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Rosiglitazone for type 2 diabetes mellitus - Richter, B - 2007 | Cochrane Library</title> <meta property="og:title" content="Rosiglitazone for type 2 diabetes mellitus - Richter, B - 2007 | Cochrane Library" /> <meta property="og:url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006063.pub2/references" /> <meta property="og:type" content="article" /> <meta property=”og:image” content=”https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png” /> <meta content="initial-scale=1.0, width=device-width" name="viewport" /> <meta name="dc.identifier" scheme="DOI" content="10.1002/14651858.CD006063.pub2" /> <meta name="citation_title" content="Rosiglitazone for type 2 diabetes mellitus" /> <meta name="citation_author" content="Bernd Richter" /> <meta name="citation_author_institution" content="Universitaetsklinikum Duesseldorf, Heinrich‐Heine University" /> <meta name="citation_author_email" content="richterb@uni-duesseldorf.de" /> <meta name="citation_author" content="Elizabeth Bandeira‐Echtler" /> <meta name="citation_author_institution" content="Universitaetsklinikum Duesseldorf, Heinrich‐Heine University" /> <meta name="citation_author" content="Karla Bergerhoff" /> <meta name="citation_author_institution" content="Universitaetsklinikum Duesseldorf, Heinrich‐Heine University" /> <meta name="citation_author" content="Christine Clar" /> <meta name="citation_author_institution" content="Cochrane Metabolic and Endocrine Disorders Group" /> <meta name="citation_author" content="Susanne H Ebrahim" /> <meta name="citation_author_institution" content="Institute for Quality and Efficiency in Health Care" /> <meta name="citation_journal_title" content="Cochrane Database of Systematic Reviews" /> <meta name="citation_publisher" content="John Wiley &amp; Sons, Ltd" /> <meta name="citation_issue" content="3" /> <meta name="citation_doi" content="10.1002/14651858.CD006063.pub2" /> <meta name="citation_date" content="2007" /> <meta name="citation_online_date" content="2007/07/18" /> <meta name="citation_abstract_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006063.pub2/abstract" /> <meta name="citation_fulltext_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006063.pub2/full" /> <meta name="citation_pdf_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006063.pub2/pdf/CDSR/CD006063/CD006063.pdf" /> <meta name="citation_issn" content="1465-1858" /> <meta name="citation_language" content="en" /> <meta name="citation_keywords" content="Diabetes Mellitus, Type 2 [*drug therapy]; Hypoglycemic Agents [adverse effects, *therapeutic use]; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones [adverse effects, *therapeutic use]" /> <script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0056/6375.js" async="async"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <script type="text/javascript">var o={auth:{customerIds:["P#DRAAEAC","EAL00000056729","DRAA3TITLES","TSINGH009S","EAL0001468","EAL00000045347"],individualId:null,brandedCustomer:"EAL0001468",roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" rel="canonical" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-CN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh_TW&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-TW" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;hr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="hr-HR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="x-default" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="en-US" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fr-FR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;de&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="de-DE" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ja&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ja-JP" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ko&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ko-KR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ms&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ms-MY" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fa&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fa-IR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pl&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pl-PL" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pt&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pt-PT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ru&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ru-RU" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;es&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="es-ES" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ta&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ta-IN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;th&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="th-TH" rel="alternate" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;aui&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link href="&#x2f;html&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1559916431000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717784000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 13},getRevision:function(){return"605.1"},getVersion:function(){return"13.0"},isAir:function(){return false},isChrome:function(){return false},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return true},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="y8F68iId";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dreferences\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006063\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006063\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article References"},article:{availableLanguage:["en","ja","ms","za"],languageCode:"en",accessStatus:"licensed",doi:"10.1002/14651858.CD006063.pub2",title:"Rosiglitazone for type 2 diabetes mellitus",firstPublishedDate:"Jul 18, 2007 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;custom&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <style type="text/css"></style> <script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-b0f13d7a13ebe8b0b1b00a9f0730a084926e292f.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1581423095000" type="text/javascript"></script> <![endif]--> </head> <body class=" yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div id="js-cookie-message" class="cookie-message cookie-message--hidden system-message-container"> <div class="container"> <a href="#" class="fa fa-times js-cookie-close pull-right" aria-label="Close cookies message"></a> <div class="system-message-wrapper container"> <i class="fa fa-exclamation-triangle" aria-hidden="true"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7XGCZUQPW4C675JNSTYTLUDN7XB/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a href="#" class="btn secondary js-cookie-close js-cookie-accept">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/"> <span class="brand-name">The Cochrane Library</span> <img class="brand-logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_logo.png" alt="Cochrane Library logo" title="Cochrane Library" /> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="owel__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006063.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006063.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a href="/en/browse-by-topic" class="btn secondary">Browse</a>
<a href="/en/advanced-search" class="btn primary advanced-search-button">Advanced search</a>
</div>
</div>
<a href="#" class="toggle-menu-switch"><i class="fa fa-bars" aria-hidden="true"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<p class="auxiliary-menu-item access">Access provided by: <strong>Tsinghua University</strong></p>
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="bvrs__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="language-selector-modal-content" style="display: none;" data-modal-title="Language selection" data-size="large"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div> <a href="/en/cdsr/doi/10.1002/14651858.CD006063.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD006063.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <button class="btn primary btn-cancel" type="button">Cancel</button> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006063.pub2%2Freferences" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
</a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
<div class="access-provider-mobile">
<p class="access">Access provided by: <strong>Tsinghua University</strong></p>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class=" nav-root-item parent">
<a href="#">Cochrane Reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_14" role="presentation">
<a aria-labelledby="layout_14" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews" role="menuitem">
Search Reviews (CDSR)
</a>
</li>
<li class=" child-nav-item" id="layout_15" role="presentation">
<a aria-labelledby="layout_15" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews&#x2f;topics" role="menuitem">
Browse Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_18" role="presentation">
<a aria-labelledby="layout_18" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;table-of-contents" role="menuitem">
Issues
</a>
</li>
<li class=" child-nav-item" id="layout_17" role="presentation">
<a aria-labelledby="layout_17" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorials" role="menuitem">
Editorials
</a>
</li>
<li class=" child-nav-item" id="layout_19" role="presentation">
<a aria-labelledby="layout_19" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;special-collections" role="menuitem">
Special Collections
</a>
</li>
<li class=" child-nav-item" id="layout_20" role="presentation">
<a aria-labelledby="layout_20" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;supplements" role="menuitem">
Supplements
</a>
</li>
<li class=" child-nav-item" id="layout_13" role="presentation">
<a aria-labelledby="layout_13" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;about-cdsr" role="menuitem">
About the CDSR
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_22" role="presentation">
<a aria-labelledby="layout_22" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central" role="menuitem">
Search Trials (CENTRAL)
</a>
</li>
<li class=" child-nav-item" id="layout_114" role="presentation">
<a aria-labelledby="layout_114" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central&#x2f;about-central" role="menuitem">
About CENTRAL
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_29" role="presentation">
<a aria-labelledby="layout_29" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca" role="menuitem">
Browse Clinical Answers
</a>
</li>
<li class=" child-nav-item" id="layout_91" role="presentation">
<a aria-labelledby="layout_91" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca&#x2f;about" role="menuitem">
About Clinical Answers
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_116" role="presentation">
<a aria-labelledby="layout_116" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-library" role="menuitem">
About the Cochrane Library
</a>
</li>
<li class=" child-nav-item" id="layout_34" role="presentation">
<a aria-labelledby="layout_34" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochrane&#x2e;org&#x2f;about-us" role="menuitem">
About Cochrane
</a>
</li>
<li class=" child-nav-item" id="layout_121" role="presentation">
<a aria-labelledby="layout_121" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-reviews" role="menuitem">
About Cochrane Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_92" role="presentation">
<a aria-labelledby="layout_92" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;author-information" role="menuitem">
Information for authors
</a>
</li>
<li class=" child-nav-item" id="layout_188" role="presentation">
<a aria-labelledby="layout_188" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;releases" role="menuitem">
What&#039;s new
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_177" role="presentation">
<a aria-labelledby="layout_177" href="https&#x3a;&#x2f;&#x2f;www&#x2e;wiley&#x2e;com&#x2f;network&#x2f;cochranelibrarytraining" role="menuitem">
Cochrane Library Training
</a>
</li>
<li class=" child-nav-item" id="layout_44" role="presentation">
<a aria-labelledby="layout_44" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;access" role="menuitem">
Access options
</a>
</li>
<li class=" child-nav-item" id="layout_150" role="presentation">
<a aria-labelledby="layout_150" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;permissions" role="menuitem">
Permissions and reprints
</a>
</li>
<li class=" child-nav-item" id="layout_93" role="presentation">
<a aria-labelledby="layout_93" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;media" role="menuitem">
Media information
</a>
</li>
<li class=" child-nav-item" id="layout_97" role="presentation">
<a aria-labelledby="layout_97" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;contact-us" role="menuitem">
Contact us
</a>
</li>
<li class=" child-nav-item" id="layout_125" role="presentation">
<a aria-labelledby="layout_125" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;terms-and-conditions" role="menuitem">
Terms and conditions
</a>
</li>
<li class=" child-nav-item" id="layout_176" role="presentation">
<a aria-labelledby="layout_176" href="https&#x3a;&#x2f;&#x2f;hub&#x2e;wiley&#x2e;com&#x2f;docs&#x2f;cochrane-library&#x2f;cochrane-library-known-issues-DOC-16221&#x3f;referrer&#x3d;cochrane" role="menuitem">
Known issues
</a>
</li>
</ul>
</li>
<li class="about-link"><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img id="etlj__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <section class="content-language-banner system-message-container" data-content-language="en" data-portal-language="en" style="display: none"> <div class="container"> <a href="#0" class="fa fa-times content-language-banner-close pull-right" aria-label="Close"></a> <i class="fa fa-globe" aria-hidden="true"></i> <div class="system-message-title">Content Language Selection</div> <div class="system-message-description">Your language preference is set to <strong class="language">English</strong>. Where translations are available, article sections will display in this language. Return to <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=reset-content-language&p_p_cacheability=cacheLevelPage" class="language secondary">English</a>.</div> </div> </section> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div id="content" class="">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="rjus__column1__0" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools"> <li class="cdsr-nav-link pulldown-menu readcube-menu closed"> <a href="#0" class="pulldown-menu-trigger"> <i class="icon fa fa-file-pdf-o"></i>View PDF <i aria-hidden="true" class="fa fa-caret-up"></i> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/pdf/full/en" class="download media pdf-link-full pdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/epdf/full/en" class="download media pdf-link-full readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/pdf/standard/en" class="download media pdf-link-standard pdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/epdf/standard/en" class="download media pdf-link-standard readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/pdf/abstract/en" class="download media pdf-link-abstract pdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/epdf/abstract/en" class="download media pdf-link-abstract readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="cdsr-nav-link cite-article-link" data-article-id="CD006063.PUB2" data-modal-title="Cite this Review"> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/#"> <i class="icon fa fa-share"></i>Cite this Review </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-english-only-message="Please note, that requesting permissions is available in English only. Apologies for any inconvenience." href="/cdsr/doi/10.1002/14651858.CD006063.pub2/#" data-copyright="Copyright © 2010 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false"> <span class="request-permissions-icon"></span> Request Permissions </a> </li> <li class="cdsr-nav-link comment-on-review"> <a id="comment-on-review" class="js-old-version-modal-trigger" href="/cdsr/doi/10.1002/14651858.CD006063.pub2/comment" data-new-version="" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience."> <i class="icon fa fa-comment"></i>Comment on Review </a> </li> <li class="cdsr-nav-link comment-on"> <a id="read-comments-on-review" class="js-old-version-modal-trigger" data-new-version="" href="/cdsr/doi/10.1002/14651858.CD006063.pub2/read-comments"> Read comments on this Review(1) </a> </li> </ul> <ul class="share clearfix"> <li class="cdsr-nav-link print-cdsr-link" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006063.pub2/print" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;zh&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh&quot;,&quot;title&quot;:&quot;概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Data and analysis&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;}]}]"> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/#"> <i class="icon fa fa-print"></i>Print </a> </li> <li class="cdsr-nav-link share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006063.pub2/full"> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/#"> <i class="icon fa fa-share-alt"></i>Share </a> </li> <li class="cdsr-nav-link"> <a href="/c/portal/login" class="article-not-followed cochrane-link signin"> <span class="article-follow-display"><i class="icon fa fa-plus"></i>Follow</span> </a> </li> </ul> <ul id="linked-articles" data-type="cdsr" class="linked-content tools clearfix linked-content-trigger"> <li> <a href="#0"> <span class="linked-to-this"> Linked to this Review <span class="linked-content-count"></span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> </li> </ul> <ul class="linked-content-dropdown"> <li data-type="cca" class="linked-cca"> <p>Cochrane Clinical Answers</p> </li> <li data-type="editorial" class="linked-editorials"> <p>Editorials</p> </li> <li data-type="podcast" class="linked-podcasts"> <p>Podcasts</p> </li> <li data-type="sc" class="linked-sc"> <p>Special Collections</p> </li> </ul> <ul class="nav-long-form"> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/full#CD006063-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/full#CD006063-sec1-0006"> Authors' conclusions </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/full#CD006063-sec1-0001"> Background </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/full#CD006063-sec1-0002"> Objectives </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/full#CD006063-sec1-0003"> Methods </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/full#CD006063-sec1-0004"> Results </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/full#CD006063-sec1-0005"> Discussion </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/appendices#CD006063-sec1-0011"> Appendices </a> </li> </ul> <ul> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/information"> Information </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/information#authors"> Authors </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/information#history"> History </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/information#keywords"> Keywords </a> </li> </ul> <ul> <li class="cdsr-nav-link bold-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/#"> <i class="icon fa fa-globe"></i>Translation notes </a> </li> </ul> <ul> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/references"> References </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/references#dataAndAnalyses"> Data and analyses </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006063.pub2/#"> <i class="icon fa fa-line-chart"></i>Figures and tables </a> </li> <li class="cdsr-nav-link download-stats-data-link " data-download-href="/cdsr/doi/10.1002/14651858.CD006063.pub2/media/CDSR/CD006063/table_n/CD006063StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/media/CDSR/CD006063/table_n/CD006063StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <i class="icon fa fa-download"></i>Download statistical data </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i>Related content <span class="note podcast-indicator">Podcast available</span> </a> </li> </ul> </nav> </div> <article class="information" data-article-id="CD006063.PUB2"> <header> <h1 class="publication-title"><h1 lang="en" class="publication-title">Rosiglitazone for type 2 diabetes mellitus</h1></h1> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div><h2 class="title section-collapse-title"> References <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <section class="references bibliographies" id="references"> <section> <div class="section-header" id="CD006063-bbs1-0001"> <h3 class="title">References to studies included in this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006063-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006063-bbs1-0003">ongoing studies</a></li> <li><a class="jump-to" href="#CD006063-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0001"> <div class="reference-title-banner"> <h4 class="title">Derosa 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0001"> <div class="citation-journal">Derosa G, Cicero AFG, D'Angelo A, Gaddi A, Ragonesi PD, Piccinni MN, Salvadeo S, Ciccarelli L, Pricolo F, Ghelfi M, Ferrari I, Montagna L, Fogari R. <span class="citation-title">Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride</span>. <span class="citation"> Hypertension Research </span><span class="pubYear">2005</span>;<span class="volume">28</span>(11):917‐924. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1291%2Fhypres.28.917" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16555581" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Thiazolidinedione+effects+on+blood+pressure+in+diabetic+patients+with+metabolic+syndrome+treated+with+glimepiride+&author=G+Derosa&author=AFG+Cicero&author=A+D'Angelo&author=A+Gaddi&author=PD+Ragonesi&author=MN+Piccinni&author=S+Salvadeo&author=L+Ciccarelli&author=F+Pricolo&author=M+Ghelfi&author=I+Ferrari&author=L+Montagna&author=R+Fogari&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28XitFSlsbw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000235429100009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 26</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0002"> <div class="citation-journal">Derosa G, Cicero AFG, Gaddi A, Ragonesi PD, Fogari E, Bertone G, et al. <span class="citation-title">Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: A twelve‐month, multicenter, double‐blind, randomized, controlled, parallel‐group trial</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2004</span>;<span class="volume">26</span>(5):744‐54. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0149-2918%2804%2990074-4" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15220018" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabolic+effects+of+pioglitazone+and+rosiglitazone+in+patients+with+diabetes+and+metabolic+syndrome+treated+with+glimepiride:+A+twelve%E2%80%90month,+multicenter,+double%E2%80%90blind,+randomized,+controlled,+parallel%E2%80%90group+trial+&author=G+Derosa&author=AFG+Cicero&author=A+Gaddi&author=PD+Ragonesi&author=E+Fogari&author=G+Bertone&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXlsFCisLs%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000221891700011&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 75</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0003"> <div class="citation-journal">Derosa G, Cicero AFG, Gaddi A, Ragonesi PD, Piccinni MN, Fogari E, Salvadeo S, Ciccarelli L, Fogari R. <span class="citation-title">A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome</span>. <span class="citation"> Diabetes Research &amp; Clinical Practice </span><span class="pubYear">2005</span>;<span class="volume">69</span>(1):5‐13. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.diabres.2004.10.007" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+the+effects+of+pioglitazone+and+rosiglitazone+combined+with+glimepiride+on+prothrombotic+state+in+type+2+diabetic+patients+with+the+metabolic+syndrome+&author=G+Derosa&author=AFG+Cicero&author=A+Gaddi&author=PD+Ragonesi&author=MN+Piccinni&author=E+Fogari&author=S+Salvadeo&author=L+Ciccarelli&author=R+Fogari&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXlt1Ghsrw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000230337300002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 37</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0002"> <div class="reference-title-banner"> <h4 class="title">Derosa 2006a {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0004"> <div class="citation-journal">Derosa G, Angelo AD, Ragonesi PD, Ciccarelli L, Piccini MN, Pricolo F, et al. <span class="citation-title">Metformin‐pioglitazone and metformin‐rosiglitazone effects on non‐conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome</span>. <span class="citation"> Journal of Clinical Pharmacology and Therapeutics </span><span class="pubYear">2006</span>;<span class="volume">31</span>:375‐83. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1365-2710.2006.00756.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin%E2%80%90pioglitazone+and+metformin%E2%80%90rosiglitazone+effects+on+non%E2%80%90conventional+cardiovascular+risk+factors+plasma+level+in+type+2+diabetic+patients+with+metabolic+syndrome+&author=G+Derosa&author=AD+Angelo&author=PD+Ragonesi&author=L+Ciccarelli&author=MN+Piccini&author=F+Pricolo&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28XpsVaru7k%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000239006500011&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 33</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0005"> <div class="citation-journal">Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, et al. <span class="citation-title">Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin</span>. <span class="citation"> Internal Medicine Journal </span><span class="pubYear">2007</span>;<span class="volume">37</span>:79‐86. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1445-5994.2007.01238.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17229249" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabolic+effects+of+pioglitazone+and+rosiglitazone+in+patients+with+diabetes+and+metabolic+syndrome+treated+with+metformin+&author=G+Derosa&author=A+D'Angelo&author=PD+Ragonesi&author=L+Ciccarelli&author=MN+Piccinni&author=F+Pricolo&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXitVCltrw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000243296100003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 15</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0003"> <div class="reference-title-banner"> <h4 class="title">Derosa 2006b {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0006"> <div class="citation-journal">Derosa G, Cicero AFG, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, et al. <span class="citation-title">Long‐term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12‐month, double‐blind, randomized trial</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2005</span>;<span class="volume">27</span>(9):1383‐90. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.clinthera.2005.09.003" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16291411" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+effects+of+glimepiride+or+rosiglitazone+in+combination+with+metformin+on+blood+pressure+control+in+type+2+diabetic+patients+affected+by+the+metabolic+syndrome:+a+12%E2%80%90month,+double%E2%80%90blind,+randomized+trial+&author=G+Derosa&author=AFG+Cicero&author=AV+Gaddi&author=L+Ciccarelli&author=MN+Piccinni&author=S+Salvadeo&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhtF2lurvF" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000232617400004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 11</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0007"> <div class="citation-journal">Derosa G, Gaddi AV, Ciccarelli L, Fogari E, Ghelfi M, Ferrari I, et al. <span class="citation-title">Long‐term effect of glimepiride and rosiglitazone on non‐conventional cardiovascular risk factors in metformin‐treated patients affected by metabolic syndrome: A randomized, double‐blind clinical trial</span>. <span class="citation"> Journal of International Medical Research </span><span class="pubYear">2005</span>;<span class="volume">33</span>(3):284‐94. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1177%2F147323000503300303" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15938589" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+effect+of+glimepiride+and+rosiglitazone+on+non%E2%80%90conventional+cardiovascular+risk+factors+in+metformin%E2%80%90treated+patients+affected+by+metabolic+syndrome:+A+randomized,+double%E2%80%90blind+clinical+trial+&author=G+Derosa&author=AV+Gaddi&author=L+Ciccarelli&author=E+Fogari&author=M+Ghelfi&author=I+Ferrari&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXlsFSktrc%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000229391100003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 9</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0008"> <div class="citation-journal">Derosa G, Gaddi AV, Piccinni MN, Ciccarelli L, Salvadeo S, Peros E, et al. <span class="citation-title">Antithrombotic effects of rosiglitazone‐metformin versus glimepiride‐metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome</span>. <span class="citation"> Pharmacotherapy </span><span class="pubYear">2005</span>;<span class="volume">25</span>(5 I):637‐45. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1592%2Fphco.25.5.637.63587" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15899724" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antithrombotic+effects+of+rosiglitazone%E2%80%90metformin+versus+glimepiride%E2%80%90metformin+combination+therapy+in+patients+with+type+2+diabetes+mellitus+and+metabolic+syndrome+&author=G+Derosa&author=AV+Gaddi&author=MN+Piccinni&author=L+Ciccarelli&author=S+Salvadeo&author=E+Peros&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXks1ais7c%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000228809200001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 17</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0009"> <div class="citation-journal">Derosa G, Gaddi AV, Piccinni MN, Salvadeo S, Ciccarelli L, Fogari E, et al. <span class="citation-title">Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double‐blind, clinical trial</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2006</span>;<span class="volume">8</span>:197‐205. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2005.00480.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Differential+effect+of+glimepiride+and+rosiglitazone+on+metabolic+control+of+type+2+diabetic+patients+treated+with+metformin:+a+randomized,+double%E2%80%90blind,+clinical+trial+&author=G+Derosa&author=AV+Gaddi&author=MN+Piccinni&author=S+Salvadeo&author=L+Ciccarelli&author=E+Fogari&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28XjsFOktrk%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000235041100010&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 15</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0004"> <div class="reference-title-banner"> <h4 class="title">Garber 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0010"> <div class="citation-journal">Garber A, Klein E, Bruce S, Sankoh S, Mohideen P. <span class="citation-title">Metformin‐glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2006</span>;<span class="volume">8</span>:156‐63. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2005.00570.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin%E2%80%90glibenclamide+versus+metformin+plus+rosiglitazone+in+patients+with+type+2+diabetes+inadequately+controlled+on+metformin+monotherapy+&author=A+Garber&author=E+Klein&author=S+Bruce&author=S+Sankoh&author=P+Mohideen&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28XjsFOktrw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000235041100005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 17</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0005"> <div class="reference-title-banner"> <h4 class="title">Goldberg 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0011"> <div class="citation-journal">Goldberg RB, Kendall DM, Deeg MA, Buse JB, Zagar AJ, Pinaire JA, et al. <span class="citation-title">A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>(7):1547‐54. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.28.7.1547" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15983299" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+lipid+and+glycemic+effects+of+pioglitazone+and+rosiglitazone+in+patients+with+type+2+diabetes+and+dyslipidemia+&author=RB+Goldberg&author=DM+Kendall&author=MA+Deeg&author=JB+Buse&author=AJ+Zagar&author=JA+Pinaire&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXms12ntLk%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000230163800001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 286</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0006"> <div class="reference-title-banner"> <h4 class="title">Hanefeld 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0012"> <div class="citation-journal">Hanefeld M, Patwardhan R, Jones NP, Rosiglitazone Clinical Trials Study Group. <span class="citation-title">A one‐year study comparing the efficacy and safety of rosiglitazone and glibenclamide in the treatment of type 2 diabetes</span>. <span class="citation"> Nutrition, Metabolism, and Cardiovascular Diseases </span><span class="pubYear">2007</span>;<span class="volume">17</span>(1):13‐23. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.numecd.2005.12.003" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+one%E2%80%90year+study+comparing+the+efficacy+and+safety+of+rosiglitazone+and+glibenclamide+in+the+treatment+of+type+2+diabetes+&author=M+Hanefeld&author=R+Patwardhan&author=NP+Jones&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD1cXlslGltQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000243954100003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 9</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0007"> <div class="reference-title-banner"> <h4 class="title">Hällsten 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0013"> <div class="citation-journal">Hällsten K, Virtanen KA, Lonnqvistt F, Janatuinen T, Turiceanu M, Ronnemaa T, et al. <span class="citation-title">Enhancement of insulin‐stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2004</span>;<span class="volume">21</span>(12):1280‐7. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2004.01332.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15569129" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Enhancement+of+insulin%E2%80%90stimulated+myocardial+glucose+uptake+in+patients+with+Type+2+diabetes+treated+with+rosiglitazone+&author=K+H%C3%A4llsten&author=KA+Virtanen&author=F+Lonnqvistt&author=T+Janatuinen&author=M+Turiceanu&author=T+Ronnemaa&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXjt1Kisw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000225768700004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 31</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0014"> <div class="citation-journal">Hällsten K, Virtanen KI, Lönnqvist F, Sipilä H, Oksanen A, Viljanen T, et al. <span class="citation-title">Rosiglitazone but not metformin enhances insulin‐ and exercise‐stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes</span>. <span class="citation"> Diabetes </span><span class="pubYear">2002</span>;<span class="volume">51</span>:3479‐85. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiabetes.51.12.3479" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12453903" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+but+not+metformin+enhances+insulin%E2%80%90+and+exercise%E2%80%90stimulated+skeletal+muscle+glucose+uptake+in+patients+with+newly+diagnosed+type+2+diabetes+&author=K+H%C3%A4llsten&author=KI+Virtanen&author=F+L%C3%B6nnqvist&author=H+Sipil%C3%A4&author=A+Oksanen&author=T+Viljanen&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD38Xptl2nurc%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000179520700018&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 63</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0015"> <div class="citation-other">Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Parkkola R, Kemppainen J, et al. <span class="citation-title">Effects of metformin and rosiglitazone monotherapy on insulin‐mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes</span>. Diabetes Care. 26 <span class="pubYear">2003</span>; Vol. 26, issue 7:2069‐74. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+and+rosiglitazone+monotherapy+on+insulin%E2%80%90mediated+hepatic+glucose+uptake+and+their+relation+to+visceral+fat+in+type+2+diabetes+&author=P+Iozzo&author=K+Hallsten&author=V+Oikonen&author=KA+Virtanen&author=R+Parkkola&author=J+Kemppainen&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0016"> <div class="citation-journal">Karlsson HK, Hallsten K, Bjornholm M, Tsuchida H, Chibalin AV, Virtanen KA, et al. <span class="citation-title">Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study</span>. <span class="citation"> Diabetes </span><span class="pubYear">2005</span>;<span class="volume">54</span>(5):1459‐67. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiabetes.54.5.1459" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15855334" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+and+rosiglitazone+treatment+on+insulin+signaling+and+glucose+uptake+in+patients+with+newly+diagnosed+type+2+diabetes:+a+randomized+controlled+study+&author=HK+Karlsson&author=K+Hallsten&author=M+Bjornholm&author=H+Tsuchida&author=AV+Chibalin&author=KA+Virtanen&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXktVCksb4%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000228701000027&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 34</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0017"> <div class="citation-journal">Viljanen APM, Virtanen KA, Järvisalo MJ, Hällsten K, Parkkola R, Rönnemaa T, et al. <span class="citation-title">Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double‐blind, randomized study with metformin</span>. <span class="citation"> Journal of Clinical Endocrinology &amp; Metabolism </span><span class="pubYear">2005</span>;<span class="volume">90</span>(12):6523‐8. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1210%2Fjc.2005-1073" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+treatment+increases+subcutaneous+adipose+tissue+glucose+uptake+in+parallel+with+perfusion+in+patients+with+type+2+diabetes:+a+double%E2%80%90blind,+randomized+study+with+metformin+&author=APM+Viljanen&author=KA+Virtanen&author=MJ+J%C3%A4rvisalo&author=K+H%C3%A4llsten&author=R+Parkkola&author=T+R%C3%B6nnemaa&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhtlaltLzK" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000233754000027&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 7</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0018"> <div class="citation-journal">Virtanen KA, Hallsten K, Parkkola R, Janatuinen T, Lonnqvist F, Viljanen T, et al. <span class="citation-title">Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects</span>. <span class="citation"> Diabetes </span><span class="pubYear">2003</span>;<span class="volume">52</span>:283‐90. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiabetes.52.2.283" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12540598" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Differential+effects+of+rosiglitazone+and+metformin+on+adipose+tissue+distribution+and+glucose+uptake+in+type+2+diabetic+subjects+&author=KA+Virtanen&author=K+Hallsten&author=R+Parkkola&author=T+Janatuinen&author=F+Lonnqvist&author=T+Viljanen&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3sXhtFagu7c%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000180891700009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 66</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0008"> <div class="reference-title-banner"> <h4 class="title">Jung 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0019"> <div class="citation-journal">Jung HS, Youn BS, Cho YM, Yu KY, Park HJ, Shin CS, et al. <span class="citation-title">The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus</span>. <span class="citation"> Metabolism: Clinical and Experimental </span><span class="pubYear">2005</span>;<span class="volume">54</span>(3):314‐20. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.metabol.2004.05.019" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15736108" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+rosiglitazone+and+metformin+on+the+plasma+concentrations+of+resistin+in+patients+with+type+2+diabetes+mellitus+&author=HS+Jung&author=BS+Youn&author=YM+Cho&author=KY+Yu&author=HJ+Park&author=CS+Shin&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhsVOjtLo%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000227663200007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 38</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0009"> <div class="reference-title-banner"> <h4 class="title">Kahn 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0020"> <div class="citation-journal">Correction to Kahn, et al. N Engl J Med 355(23):2427‐2443 December 7, 2006. <span class="citation-title">Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2007</span>;<span class="volume">356</span>(13):1387‐8. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJMx070014" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glycemic+durability+of+rosiglitazone,+metformin,+or+glyburide+monotherapy&author=Kahn+Correctionto&author=+NEnglJMed355(23):2427%E2%80%902443December7&author=+2006&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0021"> <div class="citation-journal">Gandhi GY, Montori VM. <span class="citation-title">Glycemic durability of monotherapy for diabetes</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2007</span>;<span class="volume">356</span>(13):1378‐80. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJMc063760" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17392313" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glycemic+durability+of+monotherapy+for+diabetes&author=GY+Gandhi&author=VM+Montori&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000245221000029&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 2</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0022"> <div class="citation-journal">Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, et al. ADOPT Study Group. <span class="citation-title">Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2006</span>;<span class="volume">355</span>(23):2427‐43. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJMoa066224" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17145742" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glycemic+durability+of+rosiglitazone,+metformin,+or+glyburide+monotherapy&author=SE+Kahn&author=SM+Haffner&author=MA+Heise&author=WH+Herman&author=RR+Holman&author=NP+Jones&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28Xht12ntrzF" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000242581400007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 531</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0023"> <div class="citation-journal">Nathan DM. <span class="citation-title">Thiazolidinediones for initial treatment of type 2 diabetes?</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2006</span>;<span class="volume">355</span>(23):2477‐80. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJMe068264" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17145743" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Thiazolidinediones+for+initial+treatment+of+type+2+diabetes?&author=DM+Nathan&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28Xht12nt7nF" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000242581400013&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 28</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0024"> <div class="citation-journal">Viberti G, Kahn SE, Greene DA, Herman WH, Zinman B, Holman RR, et al. <span class="citation-title">A Diabetes Outcome Progression Trial (ADOPT): An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>:1737‐43. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.25.10.1737" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12351470" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+Diabetes+Outcome+Progression+Trial+(ADOPT):+An+international+multicenter+study+of+the+comparative+efficacy+of+rosiglitazone,+glyburide,+and+metformin+in+recently+diagnosed+type+2+diabetes+&author=G+Viberti&author=SE+Kahn&author=DA+Greene&author=WH+Herman&author=B+Zinman&author=RR+Holman&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD38Xos1Wht70%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000185504500011&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 84</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0025"> <div class="citation-journal">Viberti G, Lachin J, Holman R, Zinman B, Haffner S, Kravitz MA, et al. <span class="citation-title">A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2006</span>;<span class="volume">23</span>(12):1289‐94. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2006.02022.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17116177" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+Diabetes+Outcome+Progression+Trial+(ADOPT):+baseline+characteristics+of+Type+2+diabetic+patients+in+North+America+and+Europe+&author=G+Viberti&author=J+Lachin&author=R+Holman&author=B+Zinman&author=S+Haffner&author=MA+Kravitz&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DC%2BD28nnvFCkug%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000243135700003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 12</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0010"> <div class="reference-title-banner"> <h4 class="title">Ko 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0026"> <div class="citation-journal">Ko GT, Tsang PC, Wai HP, Kan EC, Chan HC. <span class="citation-title">Rosiglitazone versus bedtime insulin in the treatment of patients with conventional oral antidiabetic drug failure: a 1‐year randomized clinical trial</span>. <span class="citation"> Advances in Therapy </span><span class="pubYear">2006</span>;<span class="volume">23</span>(5):799‐808. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2FBF02850321" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17142216" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+versus+bedtime+insulin+in+the+treatment+of+patients+with+conventional+oral+antidiabetic+drug+failure:+a+1%E2%80%90year+randomized+clinical+trial+&author=GT+Ko&author=PC+Tsang&author=HP+Wai&author=EC+Kan&author=HC+Chan&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXmslKltg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000242883400017&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 6</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0011"> <div class="reference-title-banner"> <h4 class="title">Lebovitz 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0027"> <div class="citation-journal">Haffner SM, Greenberg AS, Weston WM, Chen H, Williams K, Freed MI. <span class="citation-title">Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus</span>. <span class="citation"> Circulation </span><span class="pubYear">2002</span>;<span class="volume">106</span>(6):679‐84. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1161%2F01.CIR.0000025403.20953.23" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12163427" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+rosiglitazone+treatment+on+nontraditional+markers+of+cardiovascular+disease+in+patients+with+type+2+diabetes+mellitus+&author=SM+Haffner&author=AS+Greenberg&author=WM+Weston&author=H+Chen&author=K+Williams&author=MI+Freed&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD38XmvFSmsLw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000177401700010&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 499</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0028"> <div class="citation-journal">Lebovitz HE, Dole JF, Patwardhan R, Rappaport EB, Freed MI. <span class="citation-title">Rosiglitazone monotherapy is effective in patients with type 2 diabetes</span>. <span class="citation"> Journal of Clinical Endocrinology &amp; Metabolism </span><span class="pubYear">2001</span>;<span class="volume">86</span>(1):280‐8. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1210%2Fjc.86.1.280" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+monotherapy+is+effective+in+patients+with+type+2+diabetes&author=HE+Lebovitz&author=JF+Dole&author=R+Patwardhan&author=EB+Rappaport&author=MI+Freed&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3MXhtVGnsbo%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000166580100046&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 253</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0012"> <div class="reference-title-banner"> <h4 class="title">Ovalle 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0029"> <div class="citation-journal">Ovalle F, Bell DSH. <span class="citation-title">Effect of rosiglitazone versus insulin on the pancreatic beta‐cell function of subjects with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2004</span>;<span class="volume">27</span>(11):2585‐9. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.27.11.2585" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15504990" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+rosiglitazone+versus+insulin+on+the+pancreatic+beta%E2%80%90cell+function+of+subjects+with+type+2+diabetes+&author=F+Ovalle&author=DSH+Bell&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXhtVKis7%2FE" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000224825800003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 35</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0013"> <div class="reference-title-banner"> <h4 class="title">Phillips 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0030"> <div class="citation-journal">Phillips LS, Grunberger G, Miller E, Patwardhan R, Rappaport EB, Salzman A. <span class="citation-title">Once‐ and twice‐daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2001</span>;<span class="volume">24</span>(2):308‐15. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.24.2.308" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11213884" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Once%E2%80%90+and+twice%E2%80%90daily+dosing+with+rosiglitazone+improves+glycemic+control+in+patients+with+type+2+diabetes+&author=LS+Phillips&author=G+Grunberger&author=E+Miller&author=R+Patwardhan&author=EB+Rappaport&author=A+Salzman&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3MXhtlKhu7o%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000166681000021&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 181</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0014"> <div class="reference-title-banner"> <h4 class="title">Raskin 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0031"> <div class="citation-journal">Raskin P, McGill J, Saad MF, Cappleman JM, Kaye W, Khutoryansky N et al ‐ for the Repaglinide/Rosiglitazone Study Group. <span class="citation-title">Combination therapy for type 2 diabetes: repaglinide plus rosiglitazone</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2004</span>;<span class="volume">21</span>:329‐35. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2004.01143.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15049934" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+therapy+for+type+2+diabetes:+repaglinide+plus+rosiglitazone&author=P+Raskin&author=J+McGill&author=MF+Saad&author=JM+Cappleman&author=W+Kaye&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXktVOrs7s%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000220381200006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 20</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0015"> <div class="reference-title-banner"> <h4 class="title">Rosenstock 2006b {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0032"> <div class="citation-journal">Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes‐Rak E, Dailey G ‐ on behalf of the Insulin Glargine 4014 Study Investigators. <span class="citation-title">Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin‐naive patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2006</span>;<span class="volume">29</span>:554‐9. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.29.03.06.dc05-0695" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16505505" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+glargine+or+rosiglitazone+added+to+combination+therapy+of+sulfonylurea+plus+metformin+in+insulin%E2%80%90naive+patients+&author=J+Rosenstock&author=D+Sugimoto&author=P+Strange&author=JA+Stewart&author=E+Soltes%E2%80%90Rak&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28XislOksb4%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000235764100012&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 75</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0016"> <div class="reference-title-banner"> <h4 class="title">Stocker 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0033"> <div class="citation-journal">Stocker DJ, Taylor AJ, Langley RW, Jezior MR, Vigersky RA. <span class="citation-title">A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes</span>. <span class="citation"> American Heart Journal </span><span class="pubYear">2007</span>;<span class="volume">153</span>(3):445.e1‐6. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.ahj.2006.11.005" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+trial+of+the+effects+of+rosiglitazone+and+metformin+on+inflammation+and+subclinical+atherosclerosis+in+patients+with+type+2+diabetes+&author=DJ+Stocker&author=AJ+Taylor&author=RW+Langley&author=MR+Jezior&author=RA+Vigersky&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000244764200018&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0017"> <div class="reference-title-banner"> <h4 class="title">Sutton 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0034"> <div class="citation-journal">Bakris G, Viberti G, Weston WM, Heise M, Porter LE, Freed MI. <span class="citation-title">Rosiglitazone reduces urinary albumin excretion in type II diabetes</span>. <span class="citation"> Journal of Human Hypertension </span><span class="pubYear">2003</span>;<span class="volume">17</span>(1):7‐12. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1038%2Fsj.jhh.1001444" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12571611" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+reduces+urinary+albumin+excretion+in+type+II+diabetes&author=G+Bakris&author=G+Viberti&author=WM+Weston&author=M+Heise&author=LE+Porter&author=MI+Freed&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3sXptF2gsA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000181032400003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 133</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0035"> <div class="citation-journal">John Sutton M, Rendell M, Dandona P, Dole JF, Murphy K, Patwardhan R, et al. <span class="citation-title">A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>(11):2058‐64. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.25.11.2058" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12401757" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+the+effects+of+rosiglitazone+and+glyburide+on+cardiovascular+function+and+glycemic+control+in+patients+with+type+2+diabetes+&author=M+JohnSutton&author=M+Rendell&author=P+Dandona&author=JF+Dole&author=K+Murphy&author=R+Patwardhan&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006063-bbs2-0018"> <div class="reference-title-banner"> <h4 class="title">Yang 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0036"> <div class="citation-journal">Yang W‐S, Jeng C‐Y, Wu T‐J, Tanaka S, Funahashi T, Matsuzawa Y, et al. <span class="citation-title">Synthetic peroxisome proliferator‐activated receptor‐gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>(2):376‐80. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.25.2.376" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11815513" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Synthetic+peroxisome+proliferator%E2%80%90activated+receptor%E2%80%90gamma+agonist,+rosiglitazone,+increases+plasma+levels+of+adiponectin+in+type+2+diabetic+patients+&author=W%E2%80%90S+Yang&author=C%E2%80%90Y+Jeng&author=T%E2%80%90J+Wu&author=S+Tanaka&author=T+Funahashi&author=Y+Matsuzawa&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD38Xhtlyks7s%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000173522600021&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 234</span></a></li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006063-bbs1-0002"> <h3 class="title">References to studies excluded from this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006063-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006063-bbs1-0003">ongoing studies</a></li> <li><a class="jump-to" href="#CD006063-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0019"> <div class="reference-title-banner"> <h4 class="title">Bailey 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0037"> <div class="citation-journal">Bailey CJ, Bagdonas A, Rubes J, McMorn SO, Donaldson J, Biswas N, et al. <span class="citation-title">Rosiglitazone/metformin fixed‐dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24‐week, multicenter, randomized, double‐blind, parallel‐group study</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2005</span>;<span class="volume">27</span>(10):1548‐61. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.clinthera.2005.10.012" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16330291" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone/metformin+fixed%E2%80%90dose+combination+compared+with+uptitrated+metformin+alone+in+type+2+diabetes+mellitus:+a+24%E2%80%90week,+multicenter,+randomized,+double%E2%80%90blind,+parallel%E2%80%90group+study+&author=CJ+Bailey&author=A+Bagdonas&author=J+Rubes&author=SO+McMorn&author=J+Donaldson&author=N+Biswas&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhtlWhu7%2FE" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000233262900005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 34</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0020"> <div class="reference-title-banner"> <h4 class="title">Baksi 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0038"> <div class="citation-journal">Baksi A, James RE, Zhou B, Nolan JJ. <span class="citation-title">Comparison of uptitration of gliclazide with the addition of rosiglitazone to gliclazide in patients with type 2 diabetes inadequately controlled on half‐maximal doses of a sulphonylurea</span>. <span class="citation"> Acta Diabetologica </span><span class="pubYear">2004</span>;<span class="volume">41</span>(2):63‐9. [MEDLINE: 474] <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs00592-004-0146-y" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15224207" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+uptitration+of+gliclazide+with+the+addition+of+rosiglitazone+to+gliclazide+in+patients+with+type+2+diabetes+inadequately+controlled+on+half%E2%80%90maximal+doses+of+a+sulphonylurea+&author=A+Baksi&author=RE+James&author=B+Zhou&author=JJ+Nolan&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXlt1Glurk%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000222353600006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 18</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0021"> <div class="reference-title-banner"> <h4 class="title">Barnett 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0039"> <div class="citation-journal">Barnett AH, Grant PJ, Hitman GA, Mather H, Pawa M, Robertson L, et al. <span class="citation-title">Rosiglitazone in Type 2 diabetes mellitus: An evaluation in British Indo‐Asian patients</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2003</span>;<span class="volume">20</span>(5):387‐93. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1046%2Fj.1464-5491.2003.00925.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12752488" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+in+Type+2+diabetes+mellitus:+An+evaluation+in+British+Indo%E2%80%90Asian+patients&author=AH+Barnett&author=PJ+Grant&author=GA+Hitman&author=H+Mather&author=M+Pawa&author=L+Robertson&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3sXksFKjsbg%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000182578100008&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 14</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0022"> <div class="reference-title-banner"> <h4 class="title">Dailey 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0040"> <div class="citation-journal">Dailey III GE, Noor MA, Park J‐S, Bruce S, Fiedorek FT. <span class="citation-title">Glycemic control with Glyburide/Metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: A randomized, double‐blind trial</span>. <span class="citation"> American Journal of Medicine </span><span class="pubYear">2004</span>;<span class="volume">116</span>(4):223‐29. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.amjmed.2003.07.022" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14969649" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glycemic+control+with+Glyburide/Metformin+tablets+in+combination+with+rosiglitazone+in+patients+with+type+2+diabetes:+A+randomized,+double%E2%80%90blind+trial+&author=GE+DaileyIII&author=MA+Noor&author=J%E2%80%90S+Park&author=S+Bruce&author=FT+Fiedorek&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXht1Kls7s%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000189003300002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 51</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0023"> <div class="reference-title-banner"> <h4 class="title">Fonseca 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0041"> <div class="citation-journal">Desouza C, Fonseca VA. <span class="citation-title">Insulin sensitizer combination therapy for type 2 diabetes</span>. <span class="citation"> Cardiology Review </span><span class="pubYear">2001</span>;<span class="volume">18</span>(1):11‐15. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+sensitizer+combination+therapy+for+type+2+diabetes&author=C+Desouza&author=VA+Fonseca&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0042"> <div class="citation-journal">Fonseca V, Rosenstock J, Patwardhan R, Salzman A. <span class="citation-title">Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: A randomized controlled trial</span>. <span class="citation"> Journal of the American Medical Association </span><span class="pubYear">2000</span>;<span class="volume">283</span>(13):1695‐1702. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1001%2Fjama.283.13.1695" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10755495" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+and+rosiglitazone+combination+therapy+in+patients+with+type+2+diabetes+mellitus:+A+randomized+controlled+trial+&author=V+Fonseca&author=J+Rosenstock&author=R+Patwardhan&author=A+Salzman&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXis1Kksbg%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000086119300029&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 308</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0024"> <div class="reference-title-banner"> <h4 class="title">Fonseca 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0043"> <div class="citation-journal">Fonseca V, Grunberger G, Gupta S, Shen S, Foley JE. <span class="citation-title">Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2003</span>;<span class="volume">26</span>(6):1685‐90. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Addition+of+nateglinide+to+rosiglitazone+monotherapy+suppresses+mealtime+hyperglycemia+and+improves+overall+glycemic+control+&author=V+Fonseca&author=G+Grunberger&author=S+Gupta&author=S+Shen&author=JE+Foley&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3sXkslKrtL8%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000185505500004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 21</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0025"> <div class="reference-title-banner"> <h4 class="title">Gomez‐Perez 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0044"> <div class="citation-journal">Gomez‐Perez FJ, Fanghanel‐Salmon G, Barbosa JA, Montes‐Villarreal J, Berry RA, Warsi G, et al. <span class="citation-title">Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes</span>. <span class="citation"> Diabetes/Metabolism Research Reviews </span><span class="pubYear">2002</span>;<span class="volume">18</span>(2):127‐34. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2Fdmrr.264" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+rosiglitazone+plus+metformin+in+Mexicans+with+type+2+diabetes&author=FJ+Gomez%E2%80%90Perez&author=G+Fanghanel%E2%80%90Salmon&author=JA+Barbosa&author=J+Montes%E2%80%90Villarreal&author=RA+Berry&author=G+Warsi&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD38XktF2ntrc%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000175336300006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 60</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0026"> <div class="reference-title-banner"> <h4 class="title">Hubacek 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0045"> <div class="citation-journal">Hubacek J, Verma S, Shewchuk L, Ross SJ, Edwards A, Anderson TJ. <span class="citation-title">Rationale and design of the Glitazones and the Endothelium (GATE) study: evaluation of rosiglitazone on endothelial function in patients with diabetes</span>. <span class="citation"> Canadian Journal of Cardiology </span><span class="pubYear">2004</span>;<span class="volume">20</span>(14):1449‐53. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15614340" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rationale+and+design+of+the+Glitazones+and+the+Endothelium+(GATE)+study:+evaluation+of+rosiglitazone+on+endothelial+function+in+patients+with+diabetes+&author=J+Hubacek&author=S+Verma&author=L+Shewchuk&author=SJ+Ross&author=A+Edwards&author=TJ+Anderson&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXht1yksbs%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000225705000009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 4</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0027"> <div class="reference-title-banner"> <h4 class="title">Kerenyi 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0046"> <div class="citation-journal">Kerenyi Z, Samer H, James R, Yan Y, Stewart M. <span class="citation-title">Combination therapy with rosiglitazone and glibenclamide compared with upward titration of glibenclamide alone in patients with type 2 diabetes mellitus</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2004</span>;<span class="volume">63</span>(3):213‐23. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.diabres.2003.09.009" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14757293" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+therapy+with+rosiglitazone+and+glibenclamide+compared+with+upward+titration+of+glibenclamide+alone+in+patients+with+type+2+diabetes+mellitus+&author=Z+Kerenyi&author=H+Samer&author=R+James&author=Y+Yan&author=M+Stewart&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXmvF2lsw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000189041400007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 30</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0028"> <div class="reference-title-banner"> <h4 class="title">McCluskey 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0047"> <div class="citation-journal">McCluskey D, Touger MS, Melis R, Schleusener DS, McCluskey D. <span class="citation-title">Results of a randomized, double‐blind, placebo‐controlled study administering glimepiride to patients with type 2 diabetes mellitus inadequately controlled with rosiglitazone monotherapy</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2004</span>;<span class="volume">26</span>(11):1783‐90. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.clinthera.2004.11018" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15639690" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Results+of+a+randomized,+double%E2%80%90blind,+placebo%E2%80%90controlled+study+administering+glimepiride+to+patients+with+type+2+diabetes+mellitus+inadequately+controlled+with+rosiglitazone+monotherapy+&author=D+McCluskey&author=MS+Touger&author=R+Melis&author=DS+Schleusener&author=D+McCluskey&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXotFakuw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000225894400006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0029"> <div class="reference-title-banner"> <h4 class="title">Negro 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0048"> <div class="citation-journal">Negro R, Mangieri T, Dazzi D, Pezzarossa A, Hassan H. <span class="citation-title">Rosiglitazone effects on blood pressure and metabolic parameters in nondipper diabetic patients</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2005</span>;<span class="volume">70</span>:20‐5. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.diabres.2005.02.012" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16126119" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+effects+on+blood+pressure+and+metabolic+parameters+in+nondipper+diabetic+patients+&author=R+Negro&author=T+Mangieri&author=D+Dazzi&author=A+Pezzarossa&author=H+Hassan&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXpsVWisb0%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000232125400004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 17</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0030"> <div class="reference-title-banner"> <h4 class="title">Raskin 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0049"> <div class="citation-journal">Raskin P, Rendell M, Riddle MC, Dole JF, Freed MI, Rosenstock J ‐ Rosiglitazone‐Clinical‐Trials‐Study‐Group. <span class="citation-title">A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin‐treated type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2001</span>;<span class="volume">24</span>:1226‐32. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.24.7.1226" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11423507" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+trial+of+rosiglitazone+therapy+in+patients+with+inadequately+controlled+insulin%E2%80%90treated+type+2+diabetes+&author=P+Raskin&author=M+Rendell&author=MC+Riddle&author=JF+Dole&author=MI+Freed&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3MXlsVOrtL8%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000169520000018&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 160</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0031"> <div class="reference-title-banner"> <h4 class="title">Reynolds 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0050"> <div class="citation-journal">Reynolds LR, Konz EC, Frederich RC, Anderson JW. <span class="citation-title">Rosiglitazone amplifies the benefits of lifestyle intervention measures in long‐standing type 2 diabetes mellitus</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2002</span>;<span class="volume">4</span>(4):270‐5. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1046%2Fj.1463-1326.2002.00207.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12099976" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+amplifies+the+benefits+of+lifestyle+intervention+measures+in+long%E2%80%90standing+type+2+diabetes+mellitus+&author=LR+Reynolds&author=EC+Konz&author=RC+Frederich&author=JW+Anderson&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD38XmsVals7k%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000176642200007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 14</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0032"> <div class="reference-title-banner"> <h4 class="title">Rosenstock 2006a {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0051"> <div class="citation-journal">Herman WH, Dirani RG, Horblyuk R, O'Neill MC, Kravitz B, Heise MA et al ‐ and the RESULT Study Group. <span class="citation-title">Reduction in use of healthcare services with combination sulfonylurea and rosiglitazone: findings from the Rosiglitazone Early vs SULfonylurea Titration (RESULT) Study</span>. <span class="citation"> American Journal of Managed Care </span><span class="pubYear">2005</span>;<span class="volume">11</span>(4):273‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15839187" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Reduction+in+use+of+healthcare+services+with+combination+sulfonylurea+and+rosiglitazone:+findings+from+the+Rosiglitazone+Early+vs+SULfonylurea+Titration+(RESULT)+Study+&author=WH+Herman&author=RG+Dirani&author=R+Horblyuk&author=MC+O'Neill&author=B+Kravitz&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000228191000008&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 9</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006063-bib-0052"> <div class="citation-journal">Rosenstock J, Goldstein BJ, Vinik AI, O'Neill MO, Porter LE, Heise MA et al ‐ and the RESULT Study Group. <span class="citation-title">Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (&gt;60 years): the Rosiglitazone Early vs SULphonylurea Titration (RESULT) study</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2006</span>;<span class="volume">8</span>:49‐57. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2005.00541.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+early+addition+of+rosiglitazone+to+sulphonylurea+therapy+in+older+type+2+diabetes+patients+(>60+years):+the+Rosiglitazone+Early+vs+SULphonylurea+Titration+(RESULT)+study+&author=J+Rosenstock&author=BJ+Goldstein&author=AI+Vinik&author=MO+O'Neill&author=LE+Porter&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28XitFyjsr0%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000234976500007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 30</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0033"> <div class="reference-title-banner"> <h4 class="title">Tan 2005a {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0053"> <div class="citation-journal">Tan GD, Fielding BA, Currie JM, Humphreys SM, Desage M, Frayn KN, et al. <span class="citation-title">The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2005</span>;<span class="volume">48</span>(1):83‐95. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs00125-004-1619-9" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15619071" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+rosiglitazone+on+fatty+acid+and+triglyceride+metabolism+in+type+2+diabetes&author=GD+Tan&author=BA+Fielding&author=JM+Currie&author=SM+Humphreys&author=M+Desage&author=KN+Frayn&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXltVagtA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000226459700013&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 54</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0034"> <div class="reference-title-banner"> <h4 class="title">Tan 2005b {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0054"> <div class="citation-journal">Tan GD, Debard C, Funahashi T, Humphreys SM, Matsuzawa Y, Frayn KN, et al. <span class="citation-title">Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2005</span>;<span class="volume">48</span>(8):1585‐9. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs00125-005-1835-y" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15991021" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Changes+in+adiponectin+receptor+expression+in+muscle+and+adipose+tissue+of+type+2+diabetic+patients+during+rosiglitazone+therapy+&author=GD+Tan&author=C+Debard&author=T+Funahashi&author=SM+Humphreys&author=Y+Matsuzawa&author=KN+Frayn&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXnslyrtLw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000231219200022&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 39</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0035"> <div class="reference-title-banner"> <h4 class="title">Vongthavaravat 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0055"> <div class="citation-journal">Vongthavaravat V, Wajchenberg BL, Waitman JN, Quimpo JA, Menon PS, Ben KF, et al. <span class="citation-title">An international study of the effects of rosiglitazone plus sulphonylurea in patients with type 2 diabetes</span>. <span class="citation"> Current Medical Research and Opinion </span><span class="pubYear">2002</span>;<span class="volume">18</span>(8):456‐61. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1185%2F030079902125001236" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12564655" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=An+international+study+of+the+effects+of+rosiglitazone+plus+sulphonylurea+in+patients+with+type+2+diabetes+&author=V+Vongthavaravat&author=BL+Wajchenberg&author=JN+Waitman&author=JA+Quimpo&author=PS+Menon&author=KF+Ben&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3sXhs1Wku70%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000180703500002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 23</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0036"> <div class="reference-title-banner"> <h4 class="title">Wang 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0056"> <div class="citation-journal">Wang G, Wei J, Guan Y, Jin N, Mao J, Wang X. <span class="citation-title">Peroxisome proliferator‐activated receptor‐gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty</span>. <span class="citation"> Metabolism </span><span class="pubYear">2005</span>;<span class="volume">54</span>(5):590‐7. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.metabol.2004.11.017" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15877288" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Peroxisome+proliferator%E2%80%90activated+receptor%E2%80%90gamma+agonist+rosiglitazone+reduces+clinical+inflammatory+responses+in+type+2+diabetes+with+coronary+artery+disease+after+coronary+angioplasty+&author=G+Wang&author=J+Wei&author=Y+Guan&author=N+Jin&author=J+Mao&author=X+Wang&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXjs1Oms7k%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000229205100006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 22</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0037"> <div class="reference-title-banner"> <h4 class="title">Weissman 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0057"> <div class="citation-journal">Weissman P, Goldstein BJ, Rosenstock J, Waterhouse B, Cobitz AR, Wooddell MJ, et al. <span class="citation-title">Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study</span>. <span class="citation"> Current Medical Research and Opinion </span><span class="pubYear">2005</span>;<span class="volume">21</span>(12):2029‐35. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1185%2F030079905X74844" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16368054" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+rosiglitazone+added+to+submaximal+doses+of+metformin+compared+with+dose+escalation+of+metformin+in+type+2+diabetes:+the+EMPIRE+Study+&author=P+Weissman&author=BJ+Goldstein&author=J+Rosenstock&author=B+Waterhouse&author=AR+Cobitz&author=MJ+Wooddell&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28XhtF2ju7g%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000233990300018&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 31</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0038"> <div class="reference-title-banner"> <h4 class="title">Wolffenbuttel 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0058"> <div class="citation-journal">Wolffenbuttel BHR, Gomis R, Squatrito S, Jones NP, Patwardhan RN. <span class="citation-title">Addition of low‐dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2000</span>;<span class="volume">17</span>(1):40‐7. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1046%2Fj.1464-5491.2000.00224.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10691158" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Addition+of+low%E2%80%90dose+rosiglitazone+to+sulphonylurea+therapy+improves+glycaemic+control+in+Type+2+diabetic+patients+&author=BHR+Wolffenbuttel&author=R+Gomis&author=S+Squatrito&author=NP+Jones&author=RN+Patwardhan&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXhsFahsLw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000085461400009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 174</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0039"> <div class="reference-title-banner"> <h4 class="title">Wong 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0059"> <div class="citation-journal">Wong TYH, Szeto CC, Chow KM, Leung CB, Lam CWK, Li PKT. <span class="citation-title">Rosiglitazone reduces insulin requirements and c‐reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis</span>. <span class="citation"> American Journal of Kidney Diseases </span><span class="pubYear">2005</span>;<span class="volume">46</span>(4):713‐9. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1053%2Fj.ajkd.2005.06.020" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16183427" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+reduces+insulin+requirements+and+c%E2%80%90reactive+protein+levels+in+type+2+diabetic+patients+receiving+peritoneal+dialysis+&author=TYH+Wong&author=CC+Szeto&author=KM+Chow&author=CB+Leung&author=CWK+Lam&author=PKT+Li&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhtFGiurfL" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000233933300018&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 36</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006063-bbs2-0040"> <div class="reference-title-banner"> <h4 class="title">Zhu 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0060"> <div class="citation-journal">Zhu X‐X, Pan C‐Y, Li G‐W, Shi H‐L, Tian H, Yang W‐Y, et al. <span class="citation-title">Addition of rosiglitazone to existing sulfonylurea treatment in Chinese patients with type 2 diabetes and exposure to hepatitis B or C</span>. <span class="citation"> Diabetes Technology &amp; Therapeutics </span><span class="pubYear">2003</span>;<span class="volume">5</span>(1):33‐42. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1089%2F152091503763816445" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12725705" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Addition+of+rosiglitazone+to+existing+sulfonylurea+treatment+in+Chinese+patients+with+type+2+diabetes+and+exposure+to+hepatitis+B+or+C+&author=X%E2%80%90X+Zhu&author=C%E2%80%90Y+Pan&author=G%E2%80%90W+Li&author=H%E2%80%90L+Shi&author=H+Tian&author=W%E2%80%90Y+Yang&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3sXitlyrt7k%3D" target="_blank"><span>CAS</span></a></li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006063-bbs1-0003"> <h3 class="title">References to ongoing studies</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006063-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006063-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006063-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006063-bbs2-0041"> <div class="reference-title-banner"> <h4 class="title">RECORD {published data only} </h4> </div> <div class="bibliography-section" id="CD006063-bib-0061"> <div class="citation-journal">Home PD, Pocock SJ, Beck‐Nielsen H, Gomis R, Hanefeld M, Dargie H, et al. <span class="citation-title">Rosiglitazone evaluated for cardiac outcomes and regulation of glycaemia in diabetes (RECORD): study design and protocol</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2005</span>;<span class="volume">48</span>:1726‐35. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs00125-005-1869-1" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16025252" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+evaluated+for+cardiac+outcomes+and+regulation+of+glycaemia+in+diabetes+(RECORD):+study+design+and+protocol+&author=PD+Home&author=SJ+Pocock&author=H+Beck%E2%80%90Nielsen&author=R+Gomis&author=M+Hanefeld&author=H+Dargie&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhtVSqt7fK" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000231939300006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 68</span></a></li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006063-bbs1-0004"> <h3 class="title">Additional references</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006063-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006063-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006063-bbs1-0003">ongoing studies</a></li> </ul> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0042"> <div class="reference-title-banner"> <h4 class="title">ADA 1997</h4> </div> <div class="bibliography-section" id="CD006063-bib-0062"> <div class="citation-journal">American Diabetes Association. <span class="citation-title">Report on the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1997</span>;<span class="volume">20 Suppl 1</span>:S5‐20. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1997WA46700002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0043"> <div class="reference-title-banner"> <h4 class="title">ADA 1999</h4> </div> <div class="bibliography-section" id="CD006063-bib-0063"> <div class="citation-journal">The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. <span class="citation-title">Report of the Expert Committee on the diagnosis and classification of diabetes mellitus</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22 Suppl 1</span>:S5‐19. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0044"> <div class="reference-title-banner"> <h4 class="title">Ali 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0064"> <div class="citation-journal">Ali AA, Weinstein RA, Stewart SA, Parfitt AM, Manolagas SC, Jilka RL. <span class="citation-title">Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation</span>. <span class="citation"> Endocrinology </span><span class="pubYear">2005</span>;<span class="volume">146</span>:1226‐35. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1210%2Fen.2004-0735" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15591153" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+causes+bone+loss+in+mice+by+suppressing+osteoblast+differentiation+and+bone+formation+&author=AA+Ali&author=RA+Weinstein&author=SA+Stewart&author=AM+Parfitt&author=SC+Manolagas&author=RL+Jilka&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXitlehtro%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000227035400031&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 95</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0045"> <div class="reference-title-banner"> <h4 class="title">Armour 2004</h4> </div> <div class="bibliography-section" id="CD006063-bib-0065"> <div class="citation-journal">Armour T, Norris S, Brown D, Zhang X, Caspersen C. <span class="citation-title">Initiating and maintaining physical activity for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2004</span>, Issue 1. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD004656" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Initiating+and+maintaining+physical+activity+for+type+2+diabetes+mellitus&author=T+Armour&author=S+Norris&author=D+Brown&author=X+Zhang&author=C+Caspersen&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0046"> <div class="reference-title-banner"> <h4 class="title">Black 2003</h4> </div> <div class="bibliography-section" id="CD006063-bib-0066"> <div class="citation-journal">Black C, McIntyre L, Mesa‐Perez JA, Royle PL, Thomas S, Waugh N. <span class="citation-title">Meglitinide analogues for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2003</span>, Issue 4. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD004654" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Meglitinide+analogues+for+type+2+diabetes+mellitus&author=C+Black&author=L+McIntyre&author=JA+Mesa%E2%80%90Perez&author=PL+Royle&author=S+Thomas&author=N+Waugh&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0047"> <div class="reference-title-banner"> <h4 class="title">Bloomgarden 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0067"> <div class="citation-journal">Bloomgarden ZT. <span class="citation-title">Thiazolidinediones</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>(2):488‐93. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.28.2.488" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15677823" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Thiazolidinediones&author=ZT+Bloomgarden&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhsFOms7c%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000226612900051&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 16</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0048"> <div class="reference-title-banner"> <h4 class="title">Boucher 2002</h4> </div> <div class="bibliography-section" id="CD006063-bib-0068"> <div class="citation-other">Boucher M, McAuley L, Brown A, Keely E, Skidmore B. <span class="citation-title">Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti‐diabetic agents</span>. Ottawa, Canada: Canadian Coordinating Office for Health Technology Assessment, 2002. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0049"> <div class="reference-title-banner"> <h4 class="title">Boucher 2003</h4> </div> <div class="bibliography-section" id="CD006063-bib-0069"> <div class="citation-book">Boucher M, McAuley L, Brown A, Keely E, Skidmore B. <span class="citation">Efficacy of rosiglitazone and pioglitazone compared to other anti‐diabetic agents: systematic review and budget impact analysis</span>. Ottawa, Canada: Canadian Office for Health Technology Assessment, <span class="pubYear">2003</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0050"> <div class="reference-title-banner"> <h4 class="title">Burt 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0070"> <div class="citation-journal">Burt AL, Green S, Kwan I, Mugglestone M, Thomas J. <span class="citation-title">Intranasal insulin for type 1 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2005</span>, Issue 2. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD005269" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intranasal+insulin+for+type+1+diabetes+mellitus&author=AL+Burt&author=S+Green&author=I+Kwan&author=M+Mugglestone&author=J+Thomas&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0051"> <div class="reference-title-banner"> <h4 class="title">Chiquette 2004</h4> </div> <div class="bibliography-section" id="CD006063-bib-0071"> <div class="citation-journal">Chiquette E, Ramirez G, DeFronzo R. <span class="citation-title">A meta‐analysis comparing the effect of thiazolidinediones on cardiovascular risk factors</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">2004</span>;<span class="volume">164</span>(19):2097‐104. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1001%2Farchinte.164.19.2097" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15505122" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+meta%E2%80%90analysis+comparing+the+effect+of+thiazolidinediones+on+cardiovascular+risk+factors+&author=E+Chiquette&author=G+Ramirez&author=R+DeFronzo&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXhtVaisbvF" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000224711100003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 120</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0052"> <div class="reference-title-banner"> <h4 class="title">Cohen 1960</h4> </div> <div class="bibliography-section" id="CD006063-bib-0072"> <div class="citation-journal">Cohen J. <span class="citation-title">A coefficient of agreement for nominal scales</span>. <span class="citation"> Educational and Psychological Measurement </span><span class="pubYear">1960</span>;<span class="volume">20</span>:37‐46. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1177%2F001316446002000104" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+coefficient+of+agreement+for+nominal+scales&author=J+Cohen&publication_year=1960&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1960CCC3600004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 7814</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0053"> <div class="reference-title-banner"> <h4 class="title">Colucciello 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0073"> <div class="citation-journal">Colucciello M. <span class="citation-title">Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus</span>. <span class="citation"> Archives of Ophthalmology </span><span class="pubYear">2005</span>;<span class="volume">123</span>(9):1273‐5. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1001%2Farchopht.123.9.1273" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16157815" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Vision+loss+due+to+macular+edema+induced+by+rosiglitazone+treatment+of+diabetes+mellitus&author=M+Colucciello&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000231640100020&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 18</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0054"> <div class="reference-title-banner"> <h4 class="title">Cox 2004</h4> </div> <div class="bibliography-section" id="CD006063-bib-0074"> <div class="citation-journal">Cox SL. <span class="citation-title">Rosiglitazone maleate/metformin hydrochloride: A new formulation therapy for type 2 diabetes</span>. <span class="citation"> Drugs of Today </span><span class="pubYear">2004</span>;<span class="volume">40</span>(7):633‐43. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1358%2Fdot.2004.40.7.850480" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15510236" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+maleate/metformin+hydrochloride:+A+new+formulation+therapy+for+type+2+diabetes+&author=SL+Cox&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXovF2ktbY%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000224136400006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 8</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0055"> <div class="reference-title-banner"> <h4 class="title">Czoski‐Murray 2004</h4> </div> <div class="bibliography-section" id="CD006063-bib-0075"> <div class="citation-other">Czoski‐Murray C, Warren E, Chilcott J, Beverley C, Psyllaki MA, Cowan J. <span class="citation-title">Clinical effectiveness and cost‐effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: A systematic review and economic evaluation</span>. Winchester, England: Health Technology Assessment, 2004. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0056"> <div class="reference-title-banner"> <h4 class="title">DCCT 1993</h4> </div> <div class="bibliography-section" id="CD006063-bib-0076"> <div class="citation-journal">The diabetes control and complications trial research group. <span class="citation-title">The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus</span>. <span class="citation"> The New England Journal of Medicine </span><span class="pubYear">1993</span>;<span class="volume">329</span>(14):977‐86. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJM199309303291401" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8366922" target="_blank"> <span>PubMed</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1993LY58700001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 7940</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0057"> <div class="reference-title-banner"> <h4 class="title">DeFronzo 1992</h4> </div> <div class="bibliography-section" id="CD006063-bib-0077"> <div class="citation-journal">DeFronzo RA, Bonadonna RC, Ferrannini E. <span class="citation-title">Pathogenesis of NIDDM: a balanced overview</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1992</span>;<span class="volume">15</span>:318‐68. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.15.3.318" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1532777" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pathogenesis+of+NIDDM:+a+balanced+overview&author=RA+DeFronzo&author=RC+Bonadonna&author=E+Ferrannini&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK383hsleqtg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1992HF32300002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1356</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0058"> <div class="reference-title-banner"> <h4 class="title">Dormandy 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0078"> <div class="citation-journal">Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi‐Benedetti M, Moules IK, et al. <span class="citation-title">Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): A randomised controlled trial</span>. <span class="citation"> Lancet </span><span class="pubYear">2005</span>;<span class="volume">366</span>(9493):1279‐89. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0140-6736%2805%2967528-9" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16214598" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Secondary+prevention+of+macrovascular+events+in+patients+with+type+2+diabetes+in+the+PROactive+Study+(PROspective+pioglitAzone+Clinical+Trial+in+macroVascular+Events):+A+randomised+controlled+trial+&author=JA+Dormandy&author=B+Charbonnel&author=DJ+Eckland&author=E+Erdmann&author=M+Massi%E2%80%90Benedetti&author=IK+Moules&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhtVOlu7fO" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000232405700026&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 970</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0059"> <div class="reference-title-banner"> <h4 class="title">Ewart 2001</h4> </div> <div class="bibliography-section" id="CD006063-bib-0079"> <div class="citation-journal">Ewart RM. <span class="citation-title">The case against aggressive treatment of type 2 diabetes: critique of the UK prospective diabetes study</span>. <span class="citation"> BMJ </span><span class="pubYear">2001</span>;<span class="volume">323</span>(7317):854‐8. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.323.7317.854" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11597972" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+case+against+aggressive+treatment+of+type+2+diabetes:+critique+of+the+UK+prospective+diabetes+study+&author=RM+Ewart&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DC%2BD3MrltFSjsg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000171650500033&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 13</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0060"> <div class="reference-title-banner"> <h4 class="title">Freemantle 2003</h4> </div> <div class="bibliography-section" id="CD006063-bib-0080"> <div class="citation-journal">Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. <span class="citation-title">Composite outcomes in randomized trials: greater precision but with greater uncertainty?</span>. <span class="citation"> JAMA </span><span class="pubYear">2003</span>;<span class="volume">289</span>(19):2554‐9. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1001%2Fjama.289.19.2554" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12759327" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Composite+outcomes+in+randomized+trials:+greater+precision+but+with+greater+uncertainty?&author=N+Freemantle&author=M+Calvert&author=J+Wood&author=J+Eastaugh&author=C+Griffin&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000182976500024&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 99</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0061"> <div class="reference-title-banner"> <h4 class="title">Gimenez‐Perez 2001</h4> </div> <div class="bibliography-section" id="CD006063-bib-0081"> <div class="citation-journal">Gimenez‐Perez G, Gonzalez‐Clemente JM, Mauricio D. <span class="citation-title">Lifestyle interventions for preventing type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2001</span>, Issue 1. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD003054" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lifestyle+interventions+for+preventing+type+2+diabetes+mellitus&author=G+Gimenez%E2%80%90Perez&author=JM+Gonzalez%E2%80%90Clemente&author=D+Mauricio&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0062"> <div class="reference-title-banner"> <h4 class="title">Grey 2007</h4> </div> <div class="bibliography-section" id="CD006063-bib-0082"> <div class="citation-journal">Grey A, Bolland M, Gamble G, Wattie D, Horne A, Davidson J, et al. <span class="citation-title">The peroxisome proliferator‐activated receptor‐gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial</span>. <span class="citation"> Journal of Clinical Endocrinology and Metabolism </span> 92;<span class="volume">4</span>:1305‐10. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0063"> <div class="reference-title-banner"> <h4 class="title">Haffner 1998</h4> </div> <div class="bibliography-section" id="CD006063-bib-0083"> <div class="citation-journal">Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. <span class="citation-title">Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">1998</span>;<span class="volume">339</span>:229‐34. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJM199807233390404" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9673301" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Mortality+from+coronary+heart+disease+in+subjects+with+type+2+diabetes+and+in+nondiabetic+subjects+with+and+without+prior+myocardial+infarction+&author=SM+Haffner&author=S+Lehto&author=T+Ronnemaa&author=K+Pyorala&author=M+Laakso&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1czivVKgsg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000074918700004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 2196</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0064"> <div class="reference-title-banner"> <h4 class="title">HDS 1993</h4> </div> <div class="bibliography-section" id="CD006063-bib-0084"> <div class="citation-journal">The Hypertension in Diabetes Study Group. <span class="citation-title">Hypertension in diabetes study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications</span>. <span class="citation"> Journal of Hypertension </span><span class="pubYear">1993</span>;<span class="volume">11</span>:309‐17. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1097%2F00004872-199303000-00012" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8387089" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0065"> <div class="reference-title-banner"> <h4 class="title">Higgins 2002</h4> </div> <div class="bibliography-section" id="CD006063-bib-0085"> <div class="citation-journal">Higgins JPT, Thompson SG. <span class="citation-title">Quantifying heterogeneity in a meta‐analysis</span>. <span class="citation"> Statistics in medicine </span><span class="pubYear">2002</span>;<span class="volume">21</span>:1539‐58. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2Fsim.1186" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12111919" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Quantifying+heterogeneity+in+a+meta%E2%80%90analysis&author=JPT+Higgins&author=SG+Thompson&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000176016900005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1227</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0066"> <div class="reference-title-banner"> <h4 class="title">Higgins 2003</h4> </div> <div class="bibliography-section" id="CD006063-bib-0086"> <div class="citation-journal">Higgins JPT, Thompson SG, Deeks JJ, Altman DG. <span class="citation-title">Measuring inconsistency in meta‐analysis</span>. <span class="citation"> BMJ </span><span class="pubYear">2003</span>;<span class="volume">327</span>:557‐60. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.327.7414.557" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12958120" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Measuring+inconsistency+in+meta%E2%80%90analysis&author=JPT+Higgins&author=SG+Thompson&author=JJ+Deeks&author=DG+Altman&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000185283700028&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 15296</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0067"> <div class="reference-title-banner"> <h4 class="title">Higgins 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0087"> <div class="citation-other">Higgins JPT, Green S, editors. <span class="citation-title">Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]</span>. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley &amp; Sons, Ltd. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0068"> <div class="reference-title-banner"> <h4 class="title">Kahn 1997</h4> </div> <div class="bibliography-section" id="CD006063-bib-0088"> <div class="citation-book">Kahn SE, Porte D. <span class="citation-title">The pathophysiology of type II (noninsulindependent) diabetes mellitus: implications for treatment</span>. In: Porte D, Sherwin RS editor(s). <span class="citation">Ellenberg &amp; Rifkin's Diabetes Mellitus</span>. 5th Edition. Stamford, Conneticut (U.S.A.): Appleton &amp; Lange, <span class="pubYear">1997</span>. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+pathophysiology+of+type+II+(noninsulindependent)+diabetes+mellitus:+implications+for+treatment+&author=SE+Kahn&author=D+Porte&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0069"> <div class="reference-title-banner"> <h4 class="title">Kreider 2002</h4> </div> <div class="bibliography-section" id="CD006063-bib-0089"> <div class="citation-journal">Kreider M, Heise M. <span class="citation-title">Rosiglitazone in the management of older patients with type 2 diabetes mellitus</span>. <span class="citation"> International Journal of Clinical Practice </span><span class="pubYear">2002</span>;<span class="volume">56</span>(7):538‐41. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12296617" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+in+the+management+of+older+patients+with+type+2+diabetes+mellitus&author=M+Kreider&author=M+Heise&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD38XoslWjs7o%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000177973200009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 6</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0070"> <div class="reference-title-banner"> <h4 class="title">Laakso 1999</h4> </div> <div class="bibliography-section" id="CD006063-bib-0090"> <div class="citation-journal">Laakso M. <span class="citation-title">Hyperglycemia and cardiovascular disease in type 2 diabetes</span>. <span class="citation"> Diabetes </span><span class="pubYear">1999</span>;<span class="volume">48</span>:937‐42. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiabetes.48.5.937" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10331395" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Hyperglycemia+and+cardiovascular+disease+in+type+2+diabetes&author=M+Laakso&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK1MXjtFSgsLk%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000080214900001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 288</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0071"> <div class="reference-title-banner"> <h4 class="title">Lau 2006</h4> </div> <div class="bibliography-section" id="CD006063-bib-0091"> <div class="citation-journal">Lau J, Ioannidis JPA, Terrin N, Schmid CH, Olkin I. <span class="citation-title">The case of the misleading funnel plot</span>. <span class="citation"> BMJ </span><span class="pubYear">2006</span>;<span class="volume">333</span>:597‐600. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.333.7568.597" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16974018" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+case+of+the+misleading+funnel+plot&author=J+Lau&author=JPA+Ioannidis&author=N+Terrin&author=CH+Schmid&author=I+Olkin&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000240878200021&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 98</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0072"> <div class="reference-title-banner"> <h4 class="title">Lazarenko 2007</h4> </div> <div class="bibliography-section" id="CD006063-bib-0092"> <div class="citation-journal">Lazarenko OP, Rzonca SO, Hogue WR, Swain FL, Suva LJ, Lecka‐Czernik B. <span class="citation-title">Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone</span>. <span class="citation"> Endocrinology </span><span class="pubYear">2007</span>;<span class="volume">148</span>(6):2669‐80. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1210%2Fen.2006-1587" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17332064" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+induces+decreases+in+bone+mass+and+strength+that+are+reminiscent+of+aged+bone+&author=OP+Lazarenko&author=SO+Rzonca&author=WR+Hogue&author=FL+Swain&author=LJ+Suva&author=B+Lecka%E2%80%90Czernik&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXmt1ajt70%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000246572400015&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 35</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0073"> <div class="reference-title-banner"> <h4 class="title">Lebovitz 2002</h4> </div> <div class="bibliography-section" id="CD006063-bib-0093"> <div class="citation-journal">Lebovitz HE, Kreider M, Freed MI. <span class="citation-title">Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>:815‐21. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.25.5.815" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11978674" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Evaluation+of+liver+function+in+type+2+diabetic+patients+during+clinical+trials:+evidence+that+rosiglitazone+does+not+cause+hepatic+dysfunction+&author=HE+Lebovitz&author=M+Kreider&author=MI+Freed&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD38XjvFGnt7s%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000183491300002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 99</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0074"> <div class="reference-title-banner"> <h4 class="title">Lindberg 2002</h4> </div> <div class="bibliography-section" id="CD006063-bib-0094"> <div class="citation-journal">Lindberg G, Lindblad U, Melander A. <span class="citation-title">Sulfonylureas for treating type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2002</span>, Issue 4. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD003888" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Sulfonylureas+for+treating+type+2+diabetes+mellitus&author=G+Lindberg&author=U+Lindblad&author=A+Melander&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0075"> <div class="reference-title-banner"> <h4 class="title">Malinowski 2000</h4> </div> <div class="bibliography-section" id="CD006063-bib-0095"> <div class="citation-journal">Malinowski JM, Bolesta S. <span class="citation-title">Rosiglitazone in the treatment of type 2 diabetes mellitus: A critical review</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2000</span>;<span class="volume">22</span>(10):1151‐68. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0149-2918%2800%2983060-X" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11110228" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+in+the+treatment+of+type+2+diabetes+mellitus:+A+critical+review&author=JM+Malinowski&author=S+Bolesta&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXosFygtrg%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000165688900002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 63</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0076"> <div class="reference-title-banner"> <h4 class="title">Manson 1991</h4> </div> <div class="bibliography-section" id="CD006063-bib-0096"> <div class="citation-journal">Manson JE, Coldlitz GA, Stampfer MJ, Willet WC, Krolewski AS, Rosner B, et al. <span class="citation-title">A prospective study of maturity‐onset diabetes mellitus and risk of coronary heart disease and stroke in women</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">1991</span>;<span class="volume">151</span>:1141‐7. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1001%2Farchinte.151.6.1141" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2043016" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+prospective+study+of+maturity%E2%80%90onset+diabetes+mellitus+and+risk+of+coronary+heart+disease+and+stroke+in+women+&author=JE+Manson&author=GA+Coldlitz&author=MJ+Stampfer&author=WC+Willet&author=AS+Krolewski&author=B+Rosner&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK3M3lsVWitA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1991FQ68100013&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 398</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0077"> <div class="reference-title-banner"> <h4 class="title">Marcy 2004</h4> </div> <div class="bibliography-section" id="CD006063-bib-0097"> <div class="citation-journal">Marcy TR, Britton ML, Blevins SM. <span class="citation-title">Second‐generation thiazolidinediones and hepatotoxicity</span>. <span class="citation"> The Annals of Pharmacotherapy </span><span class="pubYear">2004</span>;<span class="volume">38</span>(9):1419‐23. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1345%2Faph.1E072" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15266041" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Second%E2%80%90generation+thiazolidinediones+and+hepatotoxicity&author=TR+Marcy&author=ML+Britton&author=SM+Blevins&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000223442300011&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 28</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0078"> <div class="reference-title-banner"> <h4 class="title">McAlister 2003</h4> </div> <div class="bibliography-section" id="CD006063-bib-0098"> <div class="citation-journal">McAlister FA, Straus SE, Sackett DL, Altman DG. <span class="citation-title">Analysis and reporting of factorial trials: a systematic review</span>. <span class="citation"> JAMA </span><span class="pubYear">2003</span>;<span class="volume">289</span>(19):2545‐53. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1001%2Fjama.289.19.2545" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12759326" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Analysis+and+reporting+of+factorial+trials:+a+systematic+review&author=FA+McAlister&author=SE+Straus&author=DL+Sackett&author=DG+Altman&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000182976500023&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 58</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0079"> <div class="reference-title-banner"> <h4 class="title">McCormack 2003</h4> </div> <div class="bibliography-section" id="CD006063-bib-0099"> <div class="citation-journal">McCormack J, Greenhalgh T. <span class="citation-title">Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study</span>. <span class="citation"> BMJ </span><span class="pubYear">2000</span>;<span class="volume">320</span>(7251):1720‐3. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.320.7251.1720" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10864554" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Seeing+what+you+want+to+see+in+randomised+controlled+trials:+versions+and+perversions+of+UKPDS+data.+United+Kingdom+prospective+diabetes+study+&author=J+McCormack&author=T+Greenhalgh&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DC%2BD3czitlSlsA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000087926400029&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 53</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0080"> <div class="reference-title-banner"> <h4 class="title">Menees 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0100"> <div class="citation-journal">Menees SB, Anderson MA, Chensue SW, Moseley RH. <span class="citation-title">Hepatic injury in a patient taking rosiglitazone</span>. <span class="citation"> Journal of Clinical Gastroenterology </span><span class="pubYear">2005</span>;<span class="volume">39</span>(7):638‐40. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1097%2F01.mcg.0000170768.59696.16" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16000935" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Hepatic+injury+in+a+patient+taking+rosiglitazone&author=SB+Menees&author=MA+Anderson&author=SW+Chensue&author=RH+Moseley&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000230863900016&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 6</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0081"> <div class="reference-title-banner"> <h4 class="title">Meriden 2004</h4> </div> <div class="bibliography-section" id="CD006063-bib-0101"> <div class="citation-journal">Meriden T. <span class="citation-title">Progress with thiazolidinediones in the management of type 2 diabetes mellitus</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2004</span>;<span class="volume">26</span>(2):177‐90. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0149-2918%2804%2990017-3" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15038941" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Progress+with+thiazolidinediones+in+the+management+of+type+2+diabetes+mellitus&author=T+Meriden&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXjtFCjtrY%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000220194600001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 29</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0082"> <div class="reference-title-banner"> <h4 class="title">Misso 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0102"> <div class="citation-journal">Misso ML, O'Connor DA, Egberts KJ, Shaw J. <span class="citation-title">Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2005</span>, Issue 1. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD005103" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Continuous+subcutaneous+insulin+infusion+(CSII)+versus+multiple+insulin+injections+for+type+1+diabetes+mellitus+&author=ML+Misso&author=DA+O'Connor&author=KJ+Egberts&author=J+Shaw&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0083"> <div class="reference-title-banner"> <h4 class="title">Moher 1999</h4> </div> <div class="bibliography-section" id="CD006063-bib-0103"> <div class="citation-journal">Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. <span class="citation-title">Improving the quality of reports of meta‐analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta‐analyses</span>. <span class="citation"> Lancet </span><span class="pubYear">1999</span>;<span class="volume">354</span>(9193):1896‐900. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0140-6736%2899%2904149-5" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10584742" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improving+the+quality+of+reports+of+meta%E2%80%90analyses+of+randomised+controlled+trials:+the+QUOROM+statement.+Quality+of+Reporting+of+Meta%E2%80%90analyses+&author=D+Moher&author=DJ+Cook&author=S+Eastwood&author=I+Olkin&author=D+Rennie&author=DF+Stroup&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DC%2BD3c%2FkvFCgtQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000083909100044&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 3022</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0084"> <div class="reference-title-banner"> <h4 class="title">Montgomery 2003</h4> </div> <div class="bibliography-section" id="CD006063-bib-0104"> <div class="citation-journal">Montgomery AA, Peters TJ, Little P. <span class="citation-title">Design, analysis and presentation of factorial randomised controlled trials</span>. <span class="citation"> BMJ </span><span class="pubYear">2003</span>;<span class="volume">3</span>:26. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Design,+analysis+and+presentation+of+factorial+randomised+controlled+trials&author=AA+Montgomery&author=TJ+Peters&author=P+Little&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0085"> <div class="reference-title-banner"> <h4 class="title">Moore 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0105"> <div class="citation-journal">Moore H, Summerbell C, Hooper, L, Ashton V, Kopelman P. <span class="citation-title">Dietary advice for the prevention of type 2 diabetes mellitus in adults</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2005</span>, Issue 1. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD005102" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Dietary+advice+for+the+prevention+of+type+2+diabetes+mellitus+in+adults&author=H+Moore&author=C+Summerbell&author=+Hooper&author=+L&author=V+Ashton&author=P+Kopelman&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0086"> <div class="reference-title-banner"> <h4 class="title">Mukhtar 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0106"> <div class="citation-journal">Mukhtar R, Reckless JPD. <span class="citation-title">Dyslipidaemia in type 2 diabetes: effects of the thiazolidinediones pioglitazone and rosiglitazone</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2005</span>;<span class="volume">22</span>:6‐10. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1466-5468.2005.01711c.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15960775" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Dyslipidaemia+in+type+2+diabetes:+effects+of+the+thiazolidinediones+pioglitazone+and+rosiglitazone+&author=R+Mukhtar&author=JPD+Reckless&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXmvFWrtLY%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000230616300002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 3</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0087"> <div class="reference-title-banner"> <h4 class="title">Nathan 1998</h4> </div> <div class="bibliography-section" id="CD006063-bib-0107"> <div class="citation-journal">Nathan DM. <span class="citation-title">Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study</span>. <span class="citation"> Lancet </span><span class="pubYear">1998</span>;<span class="volume">352</span>(9131):832‐3. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0140-6736%2898%2922937-0" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9742972" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Some+answers,+more+controversy,+from+UKPDS.+United+Kingdom+Prospective+Diabetes+Study&author=DM+Nathan&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1cvhtl2jtg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000075857300002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 94</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0088"> <div class="reference-title-banner"> <h4 class="title">NICE 2000</h4> </div> <div class="bibliography-section" id="CD006063-bib-0108"> <div class="citation-other"><span class="citation-title">Guidance on rosiglitazone for Type 2 diabetes mellitus</span>. London: National Institute for Clinical Excellence, 2000. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0089"> <div class="reference-title-banner"> <h4 class="title">NICE 2003</h4> </div> <div class="bibliography-section" id="CD006063-bib-0109"> <div class="citation-other"><span class="citation-title">Guidance on the use of glitazones for the treatment of type 2 diabetes</span>. London: National Institute for Clinical Excellence, 2003. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0090"> <div class="reference-title-banner"> <h4 class="title">NICE 2003b</h4> </div> <div class="bibliography-section" id="CD006063-bib-0110"> <div class="citation-other"><span class="citation-title">Review of rosiglitazone and pioglitazone for type II diabetes ‐ appraisal (project)</span>. London: National Institute for Clinical Excellence, 2003. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0091"> <div class="reference-title-banner"> <h4 class="title">Nissen 2007</h4> </div> <div class="bibliography-section" id="CD006063-bib-0111"> <div class="citation-journal">Nissen SE, Wolski K. <span class="citation-title">Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2007</span>;<span class="volume">356</span>:www.nejm.org (10.1056/NEJMoa072761). <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJMoa072761" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+rosiglitazone+on+the+risk+of+myocardial+infarction+and+death+from+cardiovascular+causes+&author=SE+Nissen&author=K+Wolski&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0092"> <div class="reference-title-banner"> <h4 class="title">Ohkubo 1995</h4> </div> <div class="bibliography-section" id="CD006063-bib-0112"> <div class="citation-journal">Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. <span class="citation-title">Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non‐insulin‐dependent mellitus: a randomized prospective 6‐year study</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">1995</span>;<span class="volume">28</span>:103‐17. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2F0168-8227%2895%2901064-K" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7587918" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intensive+insulin+therapy+prevents+the+progression+of+diabetic+microvascular+complications+in+Japanese+patients+with+non%E2%80%90insulin%E2%80%90dependent+mellitus:+a+randomized+prospective+6%E2%80%90year+study+&author=Y+Ohkubo&author=H+Kishikawa&author=E+Araki&author=T+Miyata&author=S+Isami&author=S+Motoyoshi&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK2MXpsVWgtrs%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1995RR63400004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1311</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0093"> <div class="reference-title-banner"> <h4 class="title">Psaty 2007</h4> </div> <div class="bibliography-section" id="CD006063-bib-0113"> <div class="citation-journal">Psaty BM, Furberg CD. <span class="citation-title">Rosiglitazone and cardiovascular risk</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2007</span>;<span class="volume">356</span>:www.nejm.org (10.1056/NEJMe078099). <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1056%2FNEJMe078099" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+and+cardiovascular+risk&author=BM+Psaty&author=CD+Furberg&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0094"> <div class="reference-title-banner"> <h4 class="title">Richter 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0114"> <div class="citation-journal">Richter B, Neises G. <span class="citation-title">'Human' insulin versus animal insulin in people with diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2005</span>, Issue 1. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15674916" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title='Human'+insulin+versus+animal+insulin+in+people+with+diabetes+mellitus&author=B+Richter&author=G+Neises&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0095"> <div class="reference-title-banner"> <h4 class="title">Richter 2006</h4> </div> <div class="bibliography-section" id="CD006063-bib-0115"> <div class="citation-journal">Richter B, Bandeira‐Echtler E, Bergerhoff K, Clar C, Ebrahim SH. <span class="citation-title">Pioglitazone for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2006</span>, Issue 4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17054272" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pioglitazone+for+type+2+diabetes+mellitus&author=B+Richter&author=E+Bandeira%E2%80%90Echtler&author=K+Bergerhoff&author=C+Clar&author=SH+Ebrahim&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0096"> <div class="reference-title-banner"> <h4 class="title">Richter 2007</h4> </div> <div class="bibliography-section" id="CD006063-bib-0116"> <div class="citation-journal">Richter B, Bandeira‐Echtler E, Bergerhoff K. <span class="citation-title">Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2007</span>, Issue 3. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD006739" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Dipeptidyl+peptidase%E2%80%904+(DPP%E2%80%904)+inhibitors+for+type+2+diabetes+mellitus&author=B+Richter&author=E+Bandeira%E2%80%90Echtler&author=K+Bergerhoff&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0097"> <div class="reference-title-banner"> <h4 class="title">Roberts 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0117"> <div class="citation-journal">Roberts D, Van NW, Chang H, Pohula W, MCheang, Moffatt M, et al. <span class="citation-title">Glargine versus other basal insulins (NPH, Lente, or Ultralente) for the treatment of type 1 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2005</span>, Issue 2. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD005271" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glargine+versus+other+basal+insulins+(NPH,+Lente,+or+Ultralente)+for+the+treatment+of+type+1+diabetes+mellitus+&author=D+Roberts&author=NW+Van&author=H+Chang&author=W+Pohula&author=+MCheang&author=M+Moffatt&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0098"> <div class="reference-title-banner"> <h4 class="title">Royle 2003</h4> </div> <div class="bibliography-section" id="CD006063-bib-0118"> <div class="citation-journal">Royle P, Waugh N, McAuley L, McIntyre L, Thomas S. <span class="citation-title">Inhaled insulin in diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2003</span>, Issue 4. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD003890.pub2" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Inhaled+insulin+in+diabetes+mellitus&author=P+Royle&author=N+Waugh&author=L+McAuley&author=L+McIntyre&author=S+Thomas&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0099"> <div class="reference-title-banner"> <h4 class="title">Ruige 1997</h4> </div> <div class="bibliography-section" id="CD006063-bib-0119"> <div class="citation-journal">Ruige JB, deNeeling JND, Kostense PJ, Bouter LM, Heine RJ. <span class="citation-title">Performance of an NIDDM screening questionnaire based on symptoms and risk factors</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1997</span>;<span class="volume">20</span>:491–6. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.20.4.491" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9096967" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Performance+of+an+NIDDM+screening+questionnaire+based+on+symptoms+and+risk+factors&author=JB+Ruige&author=JND+deNeeling&author=PJ+Kostense&author=LM+Bouter&author=RJ+Heine&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1997WP64500008&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 96</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0100"> <div class="reference-title-banner"> <h4 class="title">Saenz 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0120"> <div class="citation-journal">Saenz A, Fernandez‐Esteban I, Mataix A, Ausejo M, Roque M, Moher D. <span class="citation-title">Metformin monotherapy for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2005</span>, Issue 3. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD002966.pub3" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16034881" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+monotherapy+for+type+2+diabetes+mellitus&author=A+Saenz&author=I+Fernandez%E2%80%90Esteban&author=A+Mataix&author=M+Ausejo&author=M+Roque&author=D+Moher&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0101"> <div class="reference-title-banner"> <h4 class="title">Salpeter 2003</h4> </div> <div class="bibliography-section" id="CD006063-bib-0121"> <div class="citation-journal">Salpeter S, Greyber E, Pasternak G, Salpeter E. <span class="citation-title">Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2003</span>, Issue 3. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD002967" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12804446" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Risk+of+fatal+and+nonfatal+lactic+acidosis+with+metformin+use+in+type+2+diabetes+mellitus&author=S+Salpeter&author=E+Greyber&author=G+Pasternak&author=E+Salpeter&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0102"> <div class="reference-title-banner"> <h4 class="title">Schwartz 2006a</h4> </div> <div class="bibliography-section" id="CD006063-bib-0122"> <div class="citation-journal">Schwartz AV, Sellmeyer DE, Vittinghoff E, Palermo L, Lecka‐Czernik B, Feingold KR, et al. <span class="citation-title">Thiazolidinedione use and bone loss in older diabetic adults</span>. <span class="citation"> Journal of Clinical Endocrinology and Metabolism </span><span class="pubYear">2006</span>;<span class="volume">91</span>:3349‐54. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1210%2Fjc.2005-2226" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16608888" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Thiazolidinedione+use+and+bone+loss+in+older+diabetic+adults&author=AV+Schwartz&author=DE+Sellmeyer&author=E+Vittinghoff&author=L+Palermo&author=B+Lecka%E2%80%90Czernik&author=KR+Feingold&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28Xpslajt74%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000240358600017&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 103</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0103"> <div class="reference-title-banner"> <h4 class="title">Schwartz 2006b</h4> </div> <div class="bibliography-section" id="CD006063-bib-0123"> <div class="citation-journal">Schwartz AV. <span class="citation-title">Diabetes, TZDs, and bone: A review of the clinical evidence</span>. <span class="citation"> PPAR Research </span><span class="pubYear">2006</span>;<span class="volume">19</span>:1‐6. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1155%2FPPAR%2F2006%2F24502" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetes,+TZDs,+and+bone:+A+review+of+the+clinical+evidence&author=AV+Schwartz&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28XhtV2iu7bN" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000256333100001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0104"> <div class="reference-title-banner"> <h4 class="title">Siebenhofer 2004</h4> </div> <div class="bibliography-section" id="CD006063-bib-0124"> <div class="citation-journal">Siebenhofer A, Plank J, Berghold A, Narath M, Gfrerer R, Pieber TR. <span class="citation-title">Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2004</span>, Issue 4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Short+acting+insulin+analogues+versus+regular+human+insulin+in+patients+with+diabetes+mellitus+&author=A+Siebenhofer&author=J+Plank&author=A+Berghold&author=M+Narath&author=R+Gfrerer&author=TR+Pieber&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0105"> <div class="reference-title-banner"> <h4 class="title">Snaith 2007</h4> </div> <div class="bibliography-section" id="CD006063-bib-0125"> <div class="citation-journal">Snaith A, McIntyre L, Rothnie H, Thomas S, Royle P, Waugh N. <span class="citation-title">Glucagon‐like peptide analogues for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2007</span>, Issue 1. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD006423" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glucagon%E2%80%90like+peptide+analogues+for+type+2+diabetes+mellitus&author=A+Snaith&author=L+McIntyre&author=H+Rothnie&author=S+Thomas&author=P+Royle&author=N+Waugh&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0106"> <div class="reference-title-banner"> <h4 class="title">Stamler 1993</h4> </div> <div class="bibliography-section" id="CD006063-bib-0126"> <div class="citation-journal">Stamler J, Vaccaro O, Neaton JD, Wentworth D. <span class="citation-title">Diabetes, other risk factors, and 12‐year cardiovascular mortality for men screened in the multiple risk factor intervention trial</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1993</span>;<span class="volume">16</span>:434‐44. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.16.2.434" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8432214" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetes,+other+risk+factors,+and+12%E2%80%90year+cardiovascular+mortality+for+men+screened+in+the+multiple+risk+factor+intervention+trial+&author=J+Stamler&author=O+Vaccaro&author=JD+Neaton&author=D+Wentworth&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK3s7mtFyrtQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1993KK68200004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1828</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0107"> <div class="reference-title-banner"> <h4 class="title">Sterne 2001</h4> </div> <div class="bibliography-section" id="CD006063-bib-0127"> <div class="citation-book">Sterne JAC, Egger M, Davey Smith G. <span class="citation-title">Investigating and dealing with publication and other biases</span>. In: Egger M, Davey Smith G, Altman DG editor(s). <span class="citation">Systematic Reviews in Health Care; Meta‐analysis in Context</span>. London: BMJ Publishing Group, <span class="pubYear">2001</span>:189‐208. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Investigating+and+dealing+with+publication+and+other+biases&author=JAC+Sterne&author=M+Egger&author=G+DaveySmith&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0108"> <div class="reference-title-banner"> <h4 class="title">Stratton 2000</h4> </div> <div class="bibliography-section" id="CD006063-bib-0128"> <div class="citation-journal">Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. <span class="citation-title">Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study</span>. <span class="citation"> BMJ </span><span class="pubYear">2000</span>;<span class="volume">321</span>(7258):405‐12. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.321.7258.405" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10938048" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Association+of+glycaemia+with+macrovascular+and+microvascular+complications+of+type+2+diabetes+(UKPDS+35):+prospective+observational+study+&author=IM+Stratton&author=AI+Adler&author=HA+Neil&author=DR+Matthews&author=SE+Manley&author=CA+Cull&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DC%2BD3cvisFWnsg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000088769500019&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1690</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0109"> <div class="reference-title-banner"> <h4 class="title">Su 2006</h4> </div> <div class="bibliography-section" id="CD006063-bib-0129"> <div class="citation-journal">Su DH, Lai MY, Wu HP. <span class="citation-title">Liver failure in a patient receiving rosiglitazone therapy</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2006</span>;<span class="volume">23</span>(1):105‐6. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2006.01791.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16409577" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Liver+failure+in+a+patient+receiving+rosiglitazone+therapy&author=DH+Su&author=MY+Lai&author=HP+Wu&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000234465700020&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 3</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0110"> <div class="reference-title-banner"> <h4 class="title">Tang 2000</h4> </div> <div class="bibliography-section" id="CD006063-bib-0130"> <div class="citation-journal">Tang JL, Liu JLY. <span class="citation-title">Misleading funnel plot for detection of bias in meta‐analysis</span>. <span class="citation"> Journal of Clinical Epidemiology </span><span class="pubYear">2000</span>;<span class="volume">53</span>:477‐84. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0895-4356%2899%2900204-8" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10812319" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Misleading+funnel+plot+for+detection+of+bias+in+meta%E2%80%90analysis&author=JL+Tang&author=JLY+Liu&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DC%2BD3c3nsVSgsw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000087075500005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 92</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0111"> <div class="reference-title-banner"> <h4 class="title">Thomas 2001</h4> </div> <div class="bibliography-section" id="CD006063-bib-0131"> <div class="citation-journal">Thomas D, Elliott E. <span class="citation-title">Exercise for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2001</span>, Issue 1. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD002968" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Exercise+for+type+2+diabetes+mellitus&author=D+Thomas&author=E+Elliott&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0112"> <div class="reference-title-banner"> <h4 class="title">Thornton 2000</h4> </div> <div class="bibliography-section" id="CD006063-bib-0132"> <div class="citation-journal">Thornton A, Lee P. <span class="citation-title">Publication bias in meta‐analysis: its causes and consequences</span>. <span class="citation"> Journal of Clinical Epidemiology </span><span class="pubYear">2000</span>;<span class="volume">53</span>:207‐16. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0895-4356%2899%2900161-4" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10729693" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Publication+bias+in+meta%E2%80%90analysis:+its+causes+and+consequences&author=A+Thornton&author=P+Lee&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DC%2BD3c7psFOjsA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000086123800012&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 122</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0113"> <div class="reference-title-banner"> <h4 class="title">UGDP 1982</h4> </div> <div class="bibliography-section" id="CD006063-bib-0133"> <div class="citation-journal">University Group Diabetes Program. <span class="citation-title">Effects of hypoglycemic agents on vascular complications in patients with adult‐onset diabetes, VIII. Evaluation of insulin therapy: final report</span>. <span class="citation"> Diabetes </span><span class="pubYear">1982</span>;<span class="volume">31 Suppl 5</span>:1‐81. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6757026" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0114"> <div class="reference-title-banner"> <h4 class="title">UKPDS‐16 1995</h4> </div> <div class="bibliography-section" id="CD006063-bib-0134"> <div class="citation-journal">U.K. Prospective Diabetes Study Group. <span class="citation-title">U.K. prospective diabetes study 16: overview of 6 years' therapy of type II diabetes: a progressive disease</span>. <span class="citation"> Diabetes </span><span class="pubYear">1995</span>;<span class="volume">44</span>:1249‐58. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiabetes.44.11.1249" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7589820" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0115"> <div class="reference-title-banner"> <h4 class="title">UKPDS‐33 1998</h4> </div> <div class="bibliography-section" id="CD006063-bib-0135"> <div class="citation-journal">UK Prospective Diabetes Study Group. <span class="citation-title">Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes‐UKPDS 33</span>. <span class="citation"> Lancet </span><span class="pubYear">1998</span>;<span class="volume">352</span>:837‐52. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0140-6736%2898%2907019-6" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9742976" target="_blank"> <span>PubMed</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000075857300006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 6487</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0116"> <div class="reference-title-banner"> <h4 class="title">UKPDS‐34 1998</h4> </div> <div class="bibliography-section" id="CD006063-bib-0136"> <div class="citation-journal">UK Prospective Diabetes Study Group. <span class="citation-title">Effect of intensive blood‐glucose control with metformin on complications in overweight patients with type 2 diabetes</span>. <span class="citation"> Lancet </span><span class="pubYear">1998</span>;<span class="volume">352</span>:854‐65. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0140-6736%2898%2907037-8" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9742977" target="_blank"> <span>PubMed</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000075857300007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 2204</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0117"> <div class="reference-title-banner"> <h4 class="title">UKPDS‐38 1998</h4> </div> <div class="bibliography-section" id="CD006063-bib-0137"> <div class="citation-journal">UK Prospective Diabetes Study Group. <span class="citation-title">Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38</span>. <span class="citation"> BMJ </span><span class="pubYear">1998</span>;<span class="volume">317</span>(7160):703‐13. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.317.7160.703" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9732337" target="_blank"> <span>PubMed</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000075995100018&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 2722</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0118"> <div class="reference-title-banner"> <h4 class="title">Van de Laar 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0138"> <div class="citation-journal">Laar FA, Lucassen PLBJ, Akkermans RP, Lisdonk EH, Rutten GEHM, Van WC. <span class="citation-title">Alpha‐glucosidase inhibitors for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2005</span>, Issue 2. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15846673" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Alpha%E2%80%90glucosidase+inhibitors+for+type+2+diabetes+mellitus&author=FA+Laar&author=PLBJ+Lucassen&author=RP+Akkermans&author=EH+Lisdonk&author=GEHM+Rutten&author=WC+Van&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0119"> <div class="reference-title-banner"> <h4 class="title">Wagstaff 2002</h4> </div> <div class="bibliography-section" id="CD006063-bib-0139"> <div class="citation-journal">Wagstaff AJ, Goa KL. <span class="citation-title">Rosiglitazone: A review of its use in the management of type 2 diabetes mellitus</span>. <span class="citation"> Drugs </span><span class="pubYear">2002</span>;<span class="volume">62</span>(12):1805‐37. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2165%2F00003495-200262120-00007" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12149047" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone:+A+review+of+its+use+in+the+management+of+type+2+diabetes+mellitus&author=AJ+Wagstaff&author=KL+Goa&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD38Xntl2ktr8%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000177666500007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 84</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0120"> <div class="reference-title-banner"> <h4 class="title">Warram 1990</h4> </div> <div class="bibliography-section" id="CD006063-bib-0140"> <div class="citation-journal">Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. <span class="citation-title">Slow glucose removal rate and hyperinsulinemia precede the development of Type 2 diabetes in the offspring of diabetic parents</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1990</span>;<span class="volume">113</span>:909–15. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.7326%2F0003-4819-113-12-909" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2240915" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Slow+glucose+removal+rate+and+hyperinsulinemia+precede+the+development+of+Type+2+diabetes+in+the+offspring+of+diabetic+parents+&author=JH+Warram&author=BC+Martin&author=AS+Krolewski&author=JS+Soeldner&author=CR+Kahn&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1990EM29700003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 723</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0121"> <div class="reference-title-banner"> <h4 class="title">Wellington 2005</h4> </div> <div class="bibliography-section" id="CD006063-bib-0141"> <div class="citation-journal">Wellington K. <span class="citation-title">Rosiglitazone/Metformin</span>. <span class="citation"> Drugs </span><span class="pubYear">2005</span>;<span class="volume">65</span>(11):1581‐92. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2165%2F00003495-200565110-00013" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16033298" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone/Metformin&author=K+Wellington&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXpslSgtbg%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000230936500013&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 11</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0122"> <div class="reference-title-banner"> <h4 class="title">WHO 1980</h4> </div> <div class="bibliography-section" id="CD006063-bib-0142"> <div class="citation-other"><span class="citation-title">WHO Expert Committee on Diabetes Mellitus</span>. Geneva: World Health Organisation, 1980. Second report. Technical Report Series 646. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0123"> <div class="reference-title-banner"> <h4 class="title">WHO 1985</h4> </div> <div class="bibliography-section" id="CD006063-bib-0143"> <div class="citation-other"><span class="citation-title">WHO Expert Committee on Diabetes Mellitus</span>. Geneva: World Health Organization, 1985. Technical Report Series 727.. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0124"> <div class="reference-title-banner"> <h4 class="title">WHO 1998</h4> </div> <div class="bibliography-section" id="CD006063-bib-0144"> <div class="citation-journal">Alberti KM, Zimmet PZ. <span class="citation-title">Definition, diagnosis and classification of diabetes mellitus and its compliactions. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1998</span>;<span class="volume">15</span>:539‐53. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F%28SICI%291096-9136%28199807%2915%3A7%3C539%3A%3AAID-DIA668%3E3.0.CO%3B2-S" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9686693" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Definition,+diagnosis+and+classification+of+diabetes+mellitus+and+its+compliactions.+Part+I:+diagnosis+and+classification+of+diabetes+mellitus.+Provisional+report+of+a+WHO+consultation+&author=KM+Alberti&author=PZ+Zimmet&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1czkvFCrsA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000074777700003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 3192</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0125"> <div class="reference-title-banner"> <h4 class="title">Yang 2001</h4> </div> <div class="bibliography-section" id="CD006063-bib-0145"> <div class="citation-journal">Yang C, Chang TJ, Chang JC, Liu MW, Tai TY, Hsu WH, et al. <span class="citation-title">Rosiglitazone (BRL 49653) enhances insulin secretory response via phosphatidylinositol 3‐kinase pathway</span>. <span class="citation"> Diabetes </span><span class="pubYear">2001</span>;<span class="volume">50</span>:2598‐602. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiabetes.50.11.2598" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11679440" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+(BRL+49653)+enhances+insulin+secretory+response+via+phosphatidylinositol+3%E2%80%90kinase+pathway+&author=C+Yang&author=TJ+Chang&author=JC+Chang&author=MW+Liu&author=TY+Tai&author=WH+Hsu&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3MXotFGisL4%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000171917200025&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 25</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006063-bbs2-0126"> <div class="reference-title-banner"> <h4 class="title">Yaturu 2007</h4> </div> <div class="bibliography-section" id="CD006063-bib-0146"> <div class="citation-journal">Yaturu S, Bryant B, Jain SK. <span class="citation-title">Thiazolidinediones treatment decreases bone mineral density in type 2 diabetic men</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2007</span>;<span class="volume">0</span>:dc06‐2606v1‐0. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Thiazolidinediones+treatment+decreases+bone+mineral+density+in+type+2+diabetic+men&author=S+Yaturu&author=B+Bryant&author=SK+Jain&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> </section> <section class="characteristicStudies" id="characteristicStudies"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title"> Characteristics of studies <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="characteristicIncludedStudiesContent" lang=""> <div class="section-header" id="CD006063-sec2-0033"> <h3 class="title">Characteristics of included studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006063-sec2-0034" class="jump-to">excluded studies</a></li> <li><a href="#CD006063-sec2-0035" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Derosa 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: 12 months <br> DURATION OF FOLLOW‐UP: <br> 12 months <br> RUN‐IN PERIOD: none LANGUAGE OF PUBLICATION: English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> white patients with type 2 diabetes mellitus and metabolic syndrome <br> INCLUSION CRITERIA: <br> white patients of either sex and ages &gt;=18 years; type 2 diabetes according to ADA criteria (duration &gt;=6 months); poor glycaemic control (HbA1c &gt;=7.5% or &gt;=1 adverse effect with diet and oral hypoglycaemic agents (e.g. SU or metformin) given up to the maximum tolerated dose; all patients also diagnosed with metabolic syndrome (National Cholesterol Education Program Adult Treatment Panel III classification; triglyceridaemia (TG &gt;=150 mg/dl) and hypertension (WHO criteria BP &gt;=130/&gt;=85 mmHg); fasting C‐peptide level &gt;1.0 ng/ml <br> EXCLUSION CRITERIA: <br> receiving glimepiride, history of ketoacidosis, unstable or rapidly progressive diabetic retinopathy, nephropathy or neuropathy; impaired hepatic function, impaired renal function, severe anaemia; severe cardiovascular disease (e.g. NYHA III or IV congestive heart failure or a history of myocardial infarction or stroke) or cerebrovascular conditions within 6 months before enrolment; women who were pregnant or breastfeeding or of childbearing potential and not taking adequate contraceptive precautions <br> DIAGNOSTIC CRITERIA: <br> ADA 2001 <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> 40.2% receiving antihypertensive drugs; no patient was receiving lipid‐lowering or antiaggregant drugs </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> three <br> COUNTRY/ LOCATION: <br> Italy <br> SETTING: <br> unclear <br> INTERVENTION (DOSE/DAY): <br> rosiglitazone 4 mg once daily (before lunch); +fixed oral dose of glimepiride (4 mg/day divided into 2 doses; before breakfast and before dinner) <br> CONTROL (DOSE/DAY): <br> pioglitazone 15 mg once daily (before lunch); + fixed oral dose of glimepiride (4 mg/day divided into 2 doses; before breakfast and before dinner) <br> TREATMENT BEFORE STUDY: <br> 52.9% poor glycaemic control with metformin; 31% with SUs; 16.1% with glyburide; 14.9% with gliclazide <br> TITRATION PERIOD: <br> none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> changes in BMI, HbA1c, lipid profile, and lipoprotein variables were the primary efficacy variables SECONDARY OUTCOMES: <br> fasting and postprandial plasma glucose, insulin levels, insulin resistance (HOMA); blood pressure; adverse events </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to assess the differential effect on glucose and lipid variables of the combination of glimepiride plus pioglitazone or rosiglitazone in patients with type 2 diabetes and the metabolic syndrome </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Derosa 2006a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 12 months <br> DURATION OF FOLLOW‐UP: <br> 12 months <br> RUN‐IN PERIOD: <br> none <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Caucasian patients with type 2 diabetes and poor glycaemic control with diet or experiencing adverse effects with diet and metformin, administered up to the maximum tolerated dose <br> INCLUSION CRITERIA: <br> patients aged &gt;= 18 years of either sex if they had type 2 diabetes mellitus according to the ADA (duration &gt;= 6 months), and if they had poor glycaemic control <br> (HbA1c levels &gt; 7.5%) or <br> experienced adverse effects with diet and metformin, administered up to the maximum tolerated <br> dose; all patients were diagnosed with metabolic syndrome according to the National Cholesterol <br> Education Program Adult Treatment Panel III classification and they presented with triglyceridaemia (triglycerides &gt;= 150 mg/dL) and hypertension according to WHO 1999 criteria (systolic/diastolic BP &gt;= 130/ &gt;= 85 mmHg); all patients had a fasting C‐peptide level &gt; 1.0 ng/mL and were overweight (BMI 25.0 ‐ 28.1) <br> EXCLUSION CRITERIA: <br> history of ketoacidosis; unstable or rapidly progressive diabetic retinopathy, nephropathy, or neuropathy; impaired hepatic function (defined as plasma aminotransferase and/or gamma‐glutamyltransferase levels higher than the upper limit of normal (ULN) for age and sex], impaired renal function (defined as serum creatinine levels higher than the ULN for age and sex) or severe anaemia; patients with serious cardiovascular disease (e.g. NYHA class I–IV congestive heart failure or a history of myocardial infarction or stroke) or cerebrovascular conditions within 6 months before study enrollment; women who were pregnant, breastfeeding or of childbearing potential and not taking adequate contraceptive precautions <br> DIAGNOSTIC CRITERIA: <br> ADA 2001 <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 3 <br> COUNTRY/ LOCATION: <br> Italy <br> SETTING: <br> Department of Internal Medicine and Therapeutics, University of Pavia (Pavia, Italy); the ‘G. Descovich’ Atherosclerosis Study Center, ‘D. Campanacci’ Clinical Medicine and Applied Biotechnology Department, University of Bologna (Bologna, Italy); the Diabetes Care Unit at S. Carlo Hospital of Milano (Milano, Italy). <br> INTERVENTION (DOSE/DAY): <br> metformin (mean dose 2250 mg/day) + rosiglitazone 4 mg/day (o.d., before lunch) <br> CONTROL (DOSE/DAY): <br> metformin (mean dose 2250 mg/day) + pioglitazone 15 mg/day (15 mg o.d., before lunch) <br> TREATMENT BEFORE STUDY: <br> diet or diet and metformin, administered up to the maximum tolerated dose <br> TITRATION PERIOD: <br> all paitents received metformin beginning with a dose of 1500 mg/day and increasing up to 3000 mg/day, self‐administered for 12 months, this dose depended on the tolerance or glycaemic control of the patients (mean dosage: 2250 ± 750 mg/day) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> changes in BMI, HbA1c, lipid profile, lipoprotein variables <br> SECONDARY OUTCOMES: <br> (not stated) <br> "FPG, PPG and HOMA index <br> were also used to assess efficacy" </p> <p>BMI, HbA1c, fasting and postprandial plasma glucose (FPG, PPG) and insulin levels; HOMA; lipid profile; treatment tolerability </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to assess the differential effect on glucose and lipid variables of the combination of metformin plus pioglitazone or metformin plus rosiglitazone in patients with type 2 diabetes mellitus and metabolic syndrome. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Derosa 2006b </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 12 months <br> DURATION OF FOLLOW‐UP: <br> 12 months <br> RUN‐IN PERIOD: <br> none <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> type 2 diabetic patients with inadequate control on diet and oral hypoglycaemic agents <br> INCLUSION CRITERIA: <br> patients with metabolic syndrome diagnosis according to National Cholesterol Education Program (NCEP) (ATP III) classification and they presented at least three following components: <br> 1. type 2 diabetes mellitus. <br> 2. triglyceridemia &gt;= 150 mg/dl. <br> 3. Blood pressure &gt;= 130/85 mmHg </p> <p>type 2 diabetes mellitus, according to ADA criteria; all were required to have been diagnosed as being diabetic for at least 6 months and did not have adequate glycaemic control (as suggested by ADA guidelines) with diet and oral hypoglycaemic agents such as sulphonylureas or metformin, both to the maximum tolerated dose; no patients were taking glimepiride or thiazolidinediones; all patients had a fasting C‐peptide level &gt; 1.0 ng/ml; mean BMI of 25.3; </p> <p>furthermore, patients were hypertensive according to the WHO 1999 criteria (systolic BP &gt;= 130 mmHg and diastolic BP &gt;= 85mm Hg) and had triglyceridaemia &gt;= 150 mg/dl </p> <p>EXCLUSION CRITERIA: <br> history of ketoacidosis; unstable or rapidly progressive diabetic background retinopathy, <br> nephropathy (microalbuminuria, evaluated by proteinuria &lt;300mg/24 h) or neuropathy (evaluated by electromyography); impaired liver function (transaminases &gt; 40 U/L), impaired kidney function (creatinine &gt; 1.5mg/dl) or anaemia (Hb &lt; 11.5 g/L); unstable cardiovascular conditions (e.g. NYHA class <br> III or IV congestive heart failure or a history of myocardial infarction or stoke) or cerebrovascular conditions within 6months of study enrolment; women who were pregnant, lactating, or of child‐bearing potential while not taking adequate contraceptive precautions <br> DIAGNOSTIC CRITERIA: <br> ADA 2001 <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> at entry, 42 patients (44.2%) were taking antihypertensive drugs [16 participants, ACE‐inhibitors (38.1%); 12 participant, calcium antagonists (28.6%); 10 participants, AT II antagonists (23.8%) and four patients, alpha1‐antagonists (9.5%)]; no patients were taking lipid‐lowering or antiaggregation drugs </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 2 <br> COUNTRY/ LOCATION: <br> Italy <br> SETTING: <br> Department of Internal Medicine and Therapeutics at University of Pavia, the G. Descovich Atherosclerosis Study Center, D. Campanacci Clinical Medicine and Applied Biotechnology Department at University of Bologna <br> INTERVENTION (DOSE/DAY): <br> rosiglitazone 4 mg/day + metformin 1500 mg/day <br> CONTROL (DOSE/DAY): <br> glimepiride 2 mg/day+ metformin 1500 mg/day <br> TREATMENT BEFORE STUDY: <br> patients did not have adequate glycaemic control with diet and oral hypoglycaemic agents such as sulphonylureas or metformin, both to the maximum tolerated dose <br> TITRATION PERIOD: <br> none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> changes in BMI, HbA1c, lipid profile and lipoprotein parameters were the primary efficacy variables SECONDARY OUTCOMES: <br> (not stated) height, weight, BMI, HbA1c, FPG, PPG, fasting plasma insulin; postprandial plasma insulin; lipid profile and lipoprotein parameters; HOMA; adverse events </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> the aim of this study is to compare the metabolic changes induced by metformin associated to glimepiride or rosiglitazone in type 2 diabetic patients </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Garber 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 24 weeks <br> DURATION OF FOLLOW‐UP: <br> 24 weeks <br> RUN‐IN PERIOD: <br> during the 1‐week, open‐label lead‐in phase, patients maintained their prescreening dosage of &gt;= 1500 mg/day metformin therapy; LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> type 2 diabetes patients inadequately controlled on metformin monotherapy. <br> INCLUSION CRITERIA: <br> adults (age 20–78 years) with established type 2 diabetes requiring oral therapy; before screening, patients were required to be on a stable dosage of metformin &gt;= 1500 mg/day for &gt;= 8 weeks, HbA1c levels &gt;7.0 and &lt;= 12.0% and BMI &gt;= 23 and &lt;= 45; only patients willing and able to perform self‐blood glucose; women of childbearing potential had to practise acceptable methods of birth control and to have negative pregnancy test results within 72 h of study treatment <br> EXCLUSION CRITERIA: <br> marked polyuria and polydipsia with &gt;10% weight loss; the use of any hypoglycaemic agent other than metformin within 8 weeks before screening; anaemia [haemoglobin level: &lt;12.5 g/dl (men) and &lt;11.0 g/dl (women)] and significantly abnormal <br> renal, cardiac or hepatic dysfunction or disease; pregnant or nursing women and patients with known <br> sensitivity to any study medications were excluded. <br> DIAGNOSTIC CRITERIA: <br> not stated <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 76 <br> COUNTRY/ LOCATION: <br> USA <br> SETTING: <br> not stated <br> INTERVENTION (DOSE/DAY): <br> metformin 500 mg plus rosiglitazone 4 mg/day (initial daily dose 1000–2000 mg + 4 mg, depending on previous treatment) <br> [mean final dose of metformin plus rosiglitazone was 1819 and 7.1 mg] <br> CONTROL (DOSE/DAY): <br> metformin‐glibenclamide 500/2.5 mg/day (initial daily dose 1000/5 mg) <br> [mean final dose of metformin‐glibenclamide tablets was 1509/7.6 mg] <br> TREATMENT BEFORE STUDY: <br> patients were required to be on a stable dosage of metformin &gt;= 1500 mg/day for &gt;= 8 weeks <br> TITRATION PERIOD: <br> patients were randomly assigned to one of two double‐blind treatments, according to the dose of metformin during the lead‐in phase: <br> patients receiving 1500 mg/day metformin before screening received metformin‐glibenclamide 1000/5 mg/day (in divided doses) or metformin 1500 mg plus rosiglitazone 4 mg daily (in divided doses); those previously receiving &gt;1500 mg/day were randomly assigned to metformin‐glibenclamide 1000/5 mg (in divided doses) or metformin 2000 mg plus rosiglitazone 4 mg daily (in divided doses) </p> <p>study medications were titrated based on mean daily glucose levels to achieve a therapeutic glycaemic target </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> change in HbA1c from baseline to week 24 or the last prior blinded visit <br> SECONDARY OUTCOMES: <br> changes in body weight and changes in fructosamine, FPG, <br> 2‐h postprandial plasma glucose and fasting insulin levels from baseline to week 24 or the last prior blinded visit; proportion of patients achieving therapeutic glycaemic response (HbA1c levels &lt;7.0% and FPG levels &lt;7 mmol/L) at week 24 or the <br> last prior blinded visit; safety outcomes included adverse events, particularly hypoglycaemic symptoms; <br> standard haematology, serum chemistry and urinalysis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to compare the effects of two combination regimens, metformin‐glibenclamide combination tablets versus metformin plus rosiglitazone in patients inadequately controlled on metformin monotherapy. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Goldberg 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 24 weeks <br> DURATION OF FOLLOW‐UP: <br> 24 weeks <br> RUN‐IN PERIOD: <br> oral placebo; single‐blind; 4 weeks LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> patients with type 2 diabetes mellitus who were treated with diet alone or oral monotherapy <br> INCLUSION CRITERIA: <br> men or women &gt;= 35 years of age with a diagnosis of type 2 diabetes (WHO) with fasting triglyceride levels &gt;= 150 mg/dl and&lt; 600 mg/dl and fasting LDL cholesterol levels &lt; 130 mg/dl; fasting serum C‐peptide levels &gt;= 1 ng/ml and HbA1c values &gt;= 7 and &lt;= 11% if naive to previous oral antihyperglycemic therapy or HbA1c values &gt;= 7 and &lt;= 9.5% if previously treated with oral antihyperglycemic monotherapy. <br> EXCLUSION CRITERIA: <br> treatment within 60 days of screening with insulin, systemic glucocorticoid therapy; combination oral antihyperglycemic therapy, any lipid‐lowering agent, or any weight loss agent; known allergy to any thiazolidinedione; serum creatinine &gt;= 176.8 µmol/dl (&gt;= 2.0 mg/dl) or 2+ dipstick proteinuria at screening; ALT or AST &gt;= 1.5 times the upper limit of normal or significant clinical liver disease; hemoglobin &lt; 10.5 g/dl (females) or &lt; 11.5 g/dl (males) at screening; abnormal thyrotropin; functional NYHA class III or IV, history of CVD, or heart surgery within 6 months of screening; receiving renal dialysis or having renal transplant; current therapy for malignancy other than basal cell or squamous cell skin cancer; known history of HIV infection; signs or symptoms of drug or alcohol abuse; any condition or situation precluding adherence to and completion of the protocol. For female subjects, appropriate birth control was required, and pregnancy, breast‐feeding, or the intent to become pregnant during the study period prohibited participation. <br> DIAGNOSTIC CRITERIA: <br> WHO <br> CO‐MORBIDITIES: <br> control vs intervention: <br> ‐ pre‐existing CVD or previous myocardial infarction 8.4% vs 6.6% <br> CO‐MEDICATIONS: <br> not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 100 (USA 78) <br> COUNTRY/ LOCATION: <br> USA, Puerto Rico, Mexico, Colombia <br> SETTING: <br> not stated <br> INTERVENTION (DOSE/DAY): <br> rosiglitazone 4 mg daily for 12 weeks; thereafter 4 mg twice daily (8 mg/day) for 12 weeks <br> CONTROL (DOSE/DAY): <br> pioglitazone 30 mg daily for 12 weeks; thereafter 45 mg once daily for 12 weeks <br> TREATMENT BEFORE STUDY: <br> participants discontinued any current oral antihyperglycaemic treatment </p> <p>drug naive (%) ‐ <br> I1: 26.5, I2: 26.6, C: 28.5 <br> prior monotherapy (%) ‐ <br> I1: 68.7, I2: 65.7, C1: 63.9 <br> prior combination therapy (%) ‐ </p> <p>TITRATION PERIOD <br> ‐ pioglitazone: 30 mg daily for 12 weeks; thereafter 45 mg once daily for 12 weeks <br> ‐ rosiglitazone: 4 mg daily for 12 weeks; thereafter 4 mg twice daily (8 mg/day) for 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> triglycerides change from baseline to the last observed value SECONDARY OUTCOMES: <br> total cholesterol; plasma glucose; free fatty acids; apolipoprotein B; total insulin; C‐peptide; highly sensitive C‐reactive protein; plasminogen activator inhibitor‐1 (PAI‐1); HDL‐C; LDL‐C particle size and concentration; surrogates of insulin resistance and beta‐cell function (HOMA); safety assessments including adverse events, body weight, pedal oedema and hypoglycaemic episodes </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to test the hypothesis that pioglitazone has greater triglyceride‐lowering effects than rosiglitazone ‐ comparison of maximally effective monotherapy doses of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia receiving no concomitant glucose‐lowering or lipid‐lowering therapies </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hanefeld 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 52 weeks <br> DURATION OF FOLLOW‐UP: <br> 52 weeks <br> RUN‐IN PERIOD: <br> eligible patients on oral antidiabetic medication stopped treatment 2 weeks before starting a 4‐week, single‐blind placebo run‐in period <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> patients with type 2 diabetes <br> INCLUSION CRITERIA: <br> FPG = 7.0 ‐ 15.0 mmol/L C‐peptide &gt;= 27 nmol/L; BMI = 22 ‐ 38 <br> EXCLUSION CRITERIA: <br> patients on insulin therapy or those with diabetic complications requiring treatment, heart failure NYHA III/IV, or serious renal, hepatic (liver function tests &gt; 2.5 times the upper limit of normal). haematologic impairment or women of childbearing potential <br> DIAGNOSTIC CRITERIA: <br> see above <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 71 <br> COUNTRY/ LOCATION: <br> 8 European countries <br> SETTING: <br> not stated <br> INTERVENTION (DOSE/DAY): <br> rosiglitazone as two equal daily doses (i.e. 2 mg bid or 4 mg bid) + placebo <br> CONTROL (DOSE/DAY): <br> glibenclamide once daily + placebo <br> TREATMENT BEFORE STUDY: <br> patients on monotherapy, combination therapy or diet and exercise only <br> TITRATION PERIOD: <br> over the first 12 weeks of treatment, the glibenclamide dose was titrated in 2.5 mg increments (final dose <br> range = 2.5 ‐ 15 mg) to achieve optimal glycaemic <br> control </p> <p>a double‐dummy system allowed ‘‘titration’’ <br> of rosiglitazone without a change of dose </p> <p>concomitant medications with potential effects on glucose or lipid metabolism were kept at constant dose <br> throughout the study </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> difference between rosiglitazone 8 mg/day and glibenclamide treatment groups with respect to change from baseline in HbA1c after 52 weeks of treatment <br> SECONDARY OUTCOMES: <br> (not stated) <br> lipids, insulin resistance (HOMA), insulin, proinsulin, 32‐33 split proinsulin, safety, adverse effects </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to compare the efficacy, tolerability and safety of rosiglitazone with that of <br> glibenclamide as monotherapy for patientswith type 2 diabetes over a 12‐month treatment period </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hällsten 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 26 weeks <br> DURATION OF FOLLOW‐UP: <br> 26 weeks <br> RUN‐IN PERIOD: <br> 4‐weeks with written diet instructions <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> patients with newly diagnosed or diet‐treated type 2 diabetes <br> INCLUSION CRITERIA: <br> patients with type 2 diabetes, as defined by the WHO criteria and no diabetes complications <br> EXCLUSION CRITERIA: <br> fasting plasma glucose value &lt; 6.1 mmol/l or &gt; 11.0 mmol/L after the run‐in period; patients with cardiovascular disease, blood pressure &gt; 160/100 mm Hg, previous or present abnormal hepatic or renal function, antidiabetic medication, anemia, or oral corticosteroid treatment <br> DIAGNOSTIC CRITERIA: <br> WHO 1998 <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> not stated (1) <br> COUNTRY/ LOCATION: <br> Finland <br> SETTING: <br> the patients were recruited by advertisement and among clients of the occupational health service in Turku, Finland <br> INTERVENTION (DOSE/DAY): <br> rosiglitazone 8 mg/day (4 mg b.i.d.) <br> CONTROL (DOSE/DAY): <br> C1: metformin 2 g (1g b.i.d.) <br> C2: placebo <br> TREATMENT BEFORE STUDY: <br> none or diet only <br> TITRATION PERIOD: <br> rosiglitazone (2 mg b.i.d. for 2 weeks, thereafter 4 mg b.i.d.), metformin (500 mg b.i.d. for 2 weeks, thereafter 1 g b.i.d.), or placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> not stated (insulin‐ and exercise‐stimulated skeletal muscle glucose uptake, measured by means of positron emission tomography (PET) during euglycemic‐hyperinsulinemic <br> clamp and one‐legged exercise) <br> SECONDARY OUTCOMES: <br> (not stated) <br> FPG, insulin, HbA1c, body weight, blood pressure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to compare the effects of treatment with rosiglitazone and metformin on insulin‐ and exercise‐stimulated glucose uptake and perfusion in skeletal muscle tissue in patients with type 2 diabetes. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jung 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 6 months <br> DURATION OF FOLLOW‐UP: <br> 6 months <br> RUN‐IN PERIOD: <br> none <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Koreans with type 2 diabetes mellitus who showed poor glycaemic control with glimepiride <br> INCLUSION CRITERIA: <br> aged 20‐70 years; secondary treatment failure (HbA1c &gt; 8% on glimepiride 4 mg/day or equivalent dose of other sulfonylureas) <br> EXCLUSION CRITERIA: <br> no other severe illnesses including liver failure, renal failure, heart failure <br> DIAGNOSTIC CRITERIA: <br> not stated <br> CO‐MORBIDITIES: <br> retinopathy ‐ <br> I: 3/14, C: 3/13 <br> proteinuria ‐ <br> I: 2/14, C: 3/13 <br> coronary heart disease ‐ <br> I: 2/14, C: 2/13 <br> CO‐MEDICATIONS <br> lipid‐lowering agents ‐ <br> I: 5/14, C: 3/13 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 1 <br> COUNTRY/ LOCATION: <br> Korea <br> SETTING: <br> diabetes clinic of the Seoul National University Hospital <br> INTERVENTION (DOSE/DAY): <br> rosiglitazone 4 mg/day + glimepiride 4 mg/day <br> CONTROL (DOSE/DAY): <br> metformin 1000 mg/day + glimepiride 4 mg/day <br> TREATMENT BEFORE STUDY: <br> glimepiride 4 mg/day or equivalent dose of other sulfonylureas <br> TITRATION PERIOD: <br> none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> not stated <br> (resistin) <br> SECONDARY OUTCOMES: <br> (not stated) <br> adiponectin, FPG, lipids, HbA1c, plasma insulin, plasma C‐peptide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to see whether improving insulin resistance can modulate circulating resistin levels, the effects of two different insulin sensitizers, rosiglitazone and metformin, on plasma resistin concentrations in Korean participants with type 2 diabetes mellitus were investigated </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kahn 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 4.0 years (median) <br> DURATION OF FOLLOW‐UP: <br> 4.0 years (median) <br> RUN‐IN PERIOD: <br> 4 weeks, placebo + diet/exercise <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> people with recently diagnosed type 2 diabetes mellitus, treated with life style management only <br> INCLUSION CRITERIA: <br> eligible patients were between the ages of 30 and 75 years, with fasting plasma glucose levels ranging from 126 to 180 mg per deciliter (7.0 to 10.0 mmol per liter) while their only treatment was lifestyle management <br> EXCLUSION CRITERIA: <br> clinically significant hepatic disease, renal impairment, a history of lactic acidosis, unstable or severe angina, known congestive heart failure (CHF, New York Heart Association class I, II, III, or IV), or uncontrolled hypertension <br> DIAGNOSTIC CRITERIA: <br> "recently diagnosed (i.e., within 3 years)" <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> Antihypertensive therapy [no. (%)]: <br> I1: 744 (51.1) <br> C1: 737 (50.7) <br> C2: 753 (52.3) </p> <p>Lipid‐lowering therapy [no. (%)] <br> I1: 378 (26.0) <br> C1: 377 (25.9) <br> C2: 370 (25.7) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 488 <br> COUNTRY/ LOCATION: <br> United States, Canada, and 15 European countries <br> SETTING: <br> not stated <br> INTERVENTION (DOSE/DAY): <br> rosiglitazone (max 8 mg/day) <br> CONTROL (DOSE/DAY): <br> metformin (max 2g/day) <br> glyburide (max 15 mg/day) <br> TREATMENT BEFORE STUDY: <br> diet/exercise <br> TITRATION PERIOD: <br> patients received initial daily doses of 4 mg of rosiglitazone, 500 mg of metformin, or 2.5 mg of glyburide </p> <p>for each drug, the dose was increased according to the protocol to the maximum daily effective dose (4 mg of rosiglitazone twice daily, 1 g of metformin twice daily, and 7.5 mg of glyburide twice daily </p> <p>a dose increase was required at each visit if the fasting plasma glucose level was 140 mg per deciliter or more; a dose reduction was permitted if adverse events occurred </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> time from randomization to treatment failure, which was defined as confirmed hyperglycemia (fasting plasma glucose level, &gt;180 mg/dl) on consecutive testing after at least 6 weeks of treatment at the maximum‐dictated or maximum‐tolerated dose <br> of the study drug </p> <p>an independent adjudication <br> committee, whose members were unaware of assignments <br> to treatment groups, used prespecified criteria (available <br> at www.nejm.org) to determine whether the primary outcome <br> was reached in cases in which a confirmatory fasting plasma glucose level had not been obtained, a patient had withdrawn because of an insufficient therapeutic effect, or an additional glucose lowering drug had been administered before the <br> confirmation of hyperglycemia (according to a protocol <br> amendment adopted in February 2004) </p> <p>the threshold of more than 180 mg per deciliter for confirmed hyperglycemia was selected to <br> represent unequivocal failure in the maintenance of adequate glycemic control without incurring undue hyperglycemic symptoms; the threshold of a fasting plasma glucose level of more than <br> 140 mg per deciliter for increasing the dose of a study drug reflected clinical guidelines at the time of study design. <br> SECONDARY OUTCOMES: <br> time from randomization to a confirmed fasting plasma glucose level of more than 140 mg per deciliter after at least 6 weeks of treatment at the <br> maximum‐tolerated dose of a study drug (for patients who entered the study with a fasting plasma glucose level of 140 mg per deciliter or less) </p> <p>other prespecified outcomes were levels of fasting plasma <br> glucose and glycated hemoglobin, weight, and <br> measures of insulin sensitivity and beta‐cell function, as determined by homeostasis model assessment (HOMA 2) with the use of the HOMA calculator (www.dtu.ox.ac.uk) </p> <p>Secondary endpoints according to the published study protocol (Diabetes Care 2002):</p> <p>‐ glycaemic control <br> ‐ insulin sensitivity <br> ‐ beta‐cell function <br> ‐ cardiovascular risk markers <br> ‐ renal function <br> ‐ patient reported outcomes (quality of life) <br> ‐ resource utilization (direct health care costs will be assessed as the number of emergency room visits, number of unscheduled visits to the study physician’s office, number of hospitalizations, and length of stay. Furthermore, indirect economic costs associated <br> with bed days (days when patients stay in bed for half a day or more) and restricted activity days (days when patients reduce their usual activities, such as housework <br> or shopping) will be evaluated) <br> ‐ safety parameters (including hypoglycaemia) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to evaluate the durability of glycemic control in <br> patients receiving monotherapy with rosiglitazone, metformin or glyburide </p> <p>zhe therapeutic goal was a fasting plasma glucose <br> level below 140 mg/dl (7.8 mmol/L). </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ko 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> one year <br> DURATION OF FOLLOW‐UP: <br> one year <br> RUN‐IN PERIOD: <br> none <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Chinese patients with type 2 diabetes and conventional oral antidiabetic drugs failure <br> INCLUSION CRITERIA: <br> OAD failure was defined as persistent hyperglycaemia with haemoglobin AIc (HbA1c) &gt;= 8.5% for 6 mo or longer despite continuous use of maximal doses of conventional OAD; maximum recommended doses of various OADs were given as follows: glibenclamide 20 mg/d, gliclazide 320 mg/d, glipizide 20 mg/d, and metformin 3 g/d <br> EXCLUSION CRITERIA: <br> uncontrolled hypertension <br> with sitting blood pressure (BP) &gt;200/110 mm Hg and/or a history of myocardial <br> infarction, cerebrovascular accident, or uncontrolled congestive heart failure during the previous 6 mo, or significant renal impairment (plasma creatinine concentration &gt;= 150 mmol/L) <br> DIAGNOSTIC CRITERIA: <br> not stated <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> antihypertensive agents [no (%)]: <br> I1: 31 (55.3) <br> C1: 14 (25.0) </p> <p>lipid‐lowering agents [no (%)]: <br> I1: 5 (8.9) <br> C1: 2 (3.6) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 1 <br> COUNTRY/ LOCATION: <br> Hong Kong, China <br> SETTING: <br> Diabetic Clinic and Diabetes Center at AH Nethersole Hospital, in Tai PO, Hong Kong. <br> INTERVENTION (DOSE/DAY): <br> rosiglitazone max 8 mg/d <br> CONTROL (DOSE/DAY): <br> bedtime isophane insulin <br> TREATMENT BEFORE STUDY: <br> OAD ‐ original OAD and other medications remained the same throughout the study </p> <p>patients who fulfilled the inclusion criteria were referred to dietitians and diabetic nursing specialists for reinforcement of their dietary habits, drug compliance, and an understanding of OAD failure; those with HbA1c &gt;=8.5% three months after reinforcement were included <br> TITRATION PERIOD: <br> oral rosiglitazone was started at 2 mg/d, insulin was begun at a dose of 6 units administered at night; the insulin dose was titrated 2 to 4 wk later by a diabetic nursing specialist with an increment of 2 to 4 units according to tolerability of the insulin injection and fasting plasma glucose (PG) improvement </p> <p>at 12, 24, 36, and 52 wk, all patients were seen for assessment of tolerability <br> and compliance with treatment, and for measurement of lipid, glycemic, and other biochemical indices; insulin dosage was adjusted at each visit if this was deemed necessary, with the goal of achieving an HbA1c concentration &lt;7.5%; if the drug was tolerable to patients, rosiglitazone was also increased to the maximum dose of 8 mg <br> daily, with the goal of reducing HhA1c to &lt;7.5% without the occurrence of significant <br> hypoglycemia </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> not stated (differences in HbA1c) <br> SECONDARY OUTCOMES: <br> (not stated) <br> lipids, BMI, FPG, blood pressure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to evaluate the efficacy and tolerability of rosiglitazone in patients with secondary oral anti‐diabetic drug failure and to directly compare rosiglitazone with bedtime insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lebovitz 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 26 weeks <br> DURATION OF FOLLOW‐UP: <br> 26 weeks <br> RUN‐IN PERIOD: <br> 4‐week single blind placebo baseline period (instruction on a weight maintenance diet) <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> patients with type 2 diabetes whose hyperglycemia was inadequately controlled by diet or an oral antihyperglycemic agent <br> INCLUSION CRITERIA: <br> 36–81 years old, patients with a diagnosis of type 2 diabetes (as defined by the NDDG) if they had FPG between 7.8 –16.7 mmol/L, fasting plasma C‐peptide level greater than 0.26 nmol/L, and a body mass index (BMI) between 22–38 kg/m2 at screening <br> EXCLUSION CRITERIA: <br> patients with angina or cardiac insufficiency NYHA class III or IV; renal impairment (serum creatinine &gt; 159 mmol/L), hepatic disease (alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline <br> phosphatase, or total bilirubin, &gt; 2.5 times the upper limit of the reference range); history of diabetic ketoacidosis, history of chronic insulin use, symptomatic diabetic neuropathy; a serious major illness that would compromise their participation; women of childbearing potential <br> DIAGNOSTIC CRITERIA: <br> NDDG 1979 <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 42 <br> COUNTRY/ LOCATION: <br> USA <br> SETTING: <br> not stated <br> INTERVENTION (DOSE/DAY): <br> I1: rosiglitazone 4 mg/day <br> (2 mg twice daily) <br> I2: rosiglitazone 8 mg/day <br> (4 mg twice daily) <br> CONTROL (DOSE/DAY): <br> placebo <br> TREATMENT BEFORE STUDY: <br> diet or an oral antihyperglycemic agent </p> <p>drug naive (%) ‐ <br> I1: 26.5, I2: 26.6, C: 28.5 <br> prior monotherapy (%) ‐ <br> I1: 68.7, I2: 65.7, C1: 63.9 <br> prior combination therapy (%) ‐ </p> <p>TITRATION PERIOD: <br> screening period of up to 14 days (during which patients discontinued all antidiabetic medications); 4‐week run‐in; 26 weeks treatment period </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> change in HbA1c from baseline to 26 weeks <br> SECONDARY OUTCOMES: <br> (not stated) <br> comparisons of rosiglitazone with placebo for changes from baseline to week 26 in FPG, C‐peptide, immunoreactive insulin, proinsulin, 32–33 split proinsulin, fructosamine, urinary albumin excretion as determined by urinary albumin/creatinine ratio (ACR), and serum lipids; the proportions of patients who had a reduction in HbA1c of more than 1 percentage point or a reduction in FPG of more than 1.67 mmol/L at week 26 compared with baseline; HOMA; <br> interim medical histories, reports of adverse events, and standard laboratory assessments (including clinical chemistry, hematology, and urinalysis) were obtained at each visit; ECGs </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to assess the efficacy and safety of rosiglitazone monotherapy in patients with type 2 diabetes whose hyperglycemia was inadequately controlled by diet or an oral antihyperglycemic agent </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ovalle 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 6 months <br> DURATION OF FOLLOW‐UP: <br> 6 months <br> RUN‐IN PERIOD: <br> none <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> patients with type 2 diabetes inadequately controlled on a maximized oral antihyperglycemic double regimen of glimepiride and metformin <br> INCLUSION CRITERIA: <br> not stated <br> EXCLUSION CRITERIA: <br> not stated <br> DIAGNOSTIC CRITERIA: <br> not stated <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 1 <br> COUNTRY/ LOCATION: <br> USA <br> SETTING: <br> University of Alabama (Birmingham, Alabama, USA) <br> INTERVENTION (DOSE/DAY): <br> rosiglitazone 8 mg + metformin/sulfonylurea <br> (administered once daily) <br> CONTROL (DOSE/DAY): <br> insulin injection of 70130 mixed human insulin (administered once daily before supper) + metformin/sulfonylurea <br> TREATMENT BEFORE STUDY: <br> maximized oral antihyperglycemic double regimen of glimepiride and metformin <br> TITRATION PERIOD: <br> the dose of rosiglitazone was fixed, whereas the 70/30 insulin was started at 0.2 units/kg and adjusted to achieve a FPG level of &lt;= 120 mgldl without occurrence of severe or frequent hypoglycaemia </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> not stated (pancreatic beta‐cell function) <br> SECONDARY OUTCOMES: <br> (not stated) <br> fasting glucose, serum insulin, proinsulin levels, intravenous glucose tolerance tests, glucagon stimulation test for C‐peptide, HOMA </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to confirm that TZDs improve pancreatic beta‐cell function independent of the improvement in glycaemic control </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Phillips 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 26 weeks <br> DURATION OF FOLLOW‐UP: <br> 26 weeks <br> RUN‐IN PERIOD: <br> 4‐week placebo <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> type 2 diabetes patients <br> INCLUSION CRITERIA: <br> age 40–80 years; BMI 22–38 kg/m2; type 2 diabetes as defined by the NDDG; FPG 7.8–16.7 mmol/L (140–300 mg/dl), and fasting C‐peptide &gt;= 0.27 nmol/L (&gt;= 0.8 ng/ml) at the time of screening <br> EXCLUSION CRITERIA: <br> clinically significant renal disease, NYHA class III‐IV, coronary insufficiency or congestive heart failure, symptomatic diabetic neuropathy, or elevations in total bilirubin, alkaline phosphatase, alanine <br> aminotransferase (ALT), or aspartate aminotransferase 2.5 times the upper limit <br> DIAGNOSTIC CRITERIA: <br> NDDG 1979 <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 65 <br> COUNTRY/ LOCATION: <br> USA <br> SETTING: <br> not stated <br> INTERVENTION (DOSE/DAY): <br> I1: rosiglitazone 4 mg/day (4mg o.d) <br> I2: rosiglitazone 4 mg/day (2 mg b.i.d.) <br> I3: rosiglitazone 8 mg/day (8 mg o.d.) <br> I4: rosiglitazone 8 mg/day (4 mg b.i.d.) <br> CONTROL (DOSE/DAY): <br> placebo <br> TREATMENT BEFORE STUDY: <br> oral antihyperglycaemic agents were discontinued at least 14 days before a 4‐week placebo run‐in period </p> <p>diet only (%) ‐ <br> I1: 22.1, I2: 24.7, I3: 29.3, I4: 25.1, C: 22.5 <br> oral monotherapy (%) ‐ <br> I1: 61.3, I2: 55.9, I3: 54.7, I4: 64.7, C: 61.8 <br> oral combination therapy (%) ‐ <br> I1: 16.6, I2: 19.4, I3: 16.0, I4: 10.2, C1: 15.6 </p> <p>TITRATION PERIOD: <br> none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> change in HbA1c from baseline (end of the 4‐week placebo run‐in period) after 26 weeks of treatment <br> SECONDARY OUTCOMES: <br> the change from baseline after 26 weeks of treatment in FPG, immunoreactive insulin, C‐peptide, lipid levels </p> <p>Clinical chemistry, hematology, liver enzymes, and urinalysis; HOMA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to examine the efficacy of rosiglitazone in reducing HbA1c and to evaluate the <br> therapeutic equivalence of once‐daily and twice‐daily dosing regimens. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Raskin 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 24 weeks <br> DURATION OF FOLLOW‐UP: <br> 24 weeks <br> RUN‐IN PERIOD: <br> a screening visit was followed by a 2‐week washout period (previous diabetes medication discontinued) <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> type 2 diabetic patients who had shown treatment failure using sulphonylurea monotherapy or metformin monotherapy <br> INCLUSION CRITERIA: <br> type 2 diabetes for at least 12 months, with HbA1c values &gt; 7.0% and &lt;= 12% during previous monotherapy with sulphonylurea or metformin (at 50% or more of the maximal recommended dosages) for at least 3 months <br> EXCLUSION CRITERIA: <br> if being treated within the previous 3 months with any of the following agents: insulin, repaglinide, thiazolidinediones, alpha‐glucosidase inhibitors, or combination therapy with antidiabetic medications <br> DIAGNOSTIC CRITERIA: <br> not stated <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> not stated (multicentre) <br> COUNTRY/ LOCATION: <br> USA <br> SETTING: <br> not stated <br> INTERVENTION (DOSE/DAY): <br> I1: rosiglitazone 8.0 mg/day (mean final dose) <br> I2: rosiglitazone 6.0 mg/day (mean final dose) + repaglinide 4.0 mg/day (mean final dose) <br> CONTROL (DOSE/DAY): <br> repaglinide 12 mg/day (mean final dose) <br> TREATMENT BEFORE STUDY: <br> previous monotherapy with sulphonylurea or metformin (at 50% or more of the maximal recommended dosages) for at least 3 months: <br> previous SU/metformin (n/n/tot) ‐ <br> I1: 30/32/62, I2: 81/46/127 , <br> C: 40/23/63 <br> TITRATION PERIOD: <br> 12‐week dose‐adjustment period: <br> repaglinide monotherapy <br> was initiated at 0.5 mg per meal if HbA1c levels were &lt;= 8%, and at 1 mg per meal for all other patients; <br> the initial dosage of rosiglitazone monotherapy was 2 mg b.i.d.; <br> repaglinide/rosiglitazone combination therapy was initiated at 0.5 mg or 1 mg repaglinide per meal (adjusted according to HbA1c as above), plus 2 mg rosiglitazone b.i.d. </p> <p>all patients in groups treated with repaglinide (monotherapy or combination) could have dosage adjusted up to a maximal dose of 4 mg per meal; the rosiglitazone dosage could be doubled in monotherapy or combination therapy groups at week 12, up to a maximum dose not to exceed 4 mg b.i.d.; the dose‐adjustment period was followed by 12 additional <br> weeks of maintenance therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> change in HbA1c values from baseline to the end of study treatment <br> SECONDARY OUTCOMES: <br> changes in FPG values; <br> alanine aminotransferase (ALT); lipids; adverse events and reports of hypoglycemic episodes </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to investigate the therapeutic effects <br> of repaglinide combination therapy with rosiglitazone; the efficacy, safety, and tolerability of the combination were compared with those of monotherapy with either agent alone, in patients who had shown treatment failure using sulphonylurea monotherapy or metformin monotherapy </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rosenstock 2006b </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 24 weeks <br> DURATION OF FOLLOW‐UP: <br> 24 weeks <br> RUN‐IN PERIOD: <br> during the screening/titration phase, patients not on the maximum metformin dose were titrated to 2000 mg/day; patients on 1000 mg/day increased their dose to 1500 mg/day immediately and to 2000 mg/day 1 week later (or maximum tolerated dose), followed by a 2‐week stabilization period; patients on 1500 mg/ day increased their dose to 2000 mg/day immediately followed by a 2‐week stabilization period <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> insulin‐naive patients with type 2 diabetes inadequately controlled on dual oral therapy with sulfonylurea plus metformin <br> INCLUSION CRITERIA: <br> participants &gt;= 18 years of age with type 2 diabetes (HbA1c &gt;= 7.5 and &lt;= 11%) and a BMI of &gt; 25; continuous oral hypoglycemic treatment using stable daily doses of &gt;= 50% of the maximally labeled dose of a sulfonylurea and at least 1000 mg metformin was required for &gt;= 3 months before the screening <br> visit <br> EXCLUSION CRITERIA: <br> stroke, myocardial infarction, angina pectoris, coronary artery bypass graft, or percutaneous transluminal coronary angioplasty within the previous 12 months; history of congestive heart failure; treatment with nonselective beta‐blockers; hypoglycemia unawareness; impaired renal function; active liver disease; substance or alcohol abuse; malignancy; planned radiological examinations requiring administration of contrasting agents <br> DIAGNOSTIC CRITERIA: <br> HbA1c &gt;= 7.5 and &lt;= 11% <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 42 <br> COUNTRY/ LOCATION: <br> USA <br> SETTING: <br> not stated <br> INTERVENTION (DOSE/DAY): <br> &gt;= 50% of maximal‐dose sulfonylurea and metformin + rosiglitazone 4 mg/day (mean daily dose rosiglitazone <br> was 7.1 +‐ 1.7 mg) <br> CONTROL (DOSE/DAY): <br> &gt;= 50% of maximal‐dose sulfonylurea and metformin + insulin glargine 10 units/day (mean daily dose of insulin <br> glargine was 38.5 +‐ 26.5 IU) <br> TREATMENT BEFORE STUDY: <br> slfonylurea and metformin doses remained unchanged during the treatment phase of the study <br> TITRATION PERIOD: <br> (see run‐in phase) <br> all patients randomized to insulin glargine received a single daily subcutaneous injection at bedtime at a starting dose of 10 IU/day for 7days, the dose was titrated weekly according to self‐monitored FPG, supervised centrally to ensure compliance, to meet target FPG &lt;100 –120 mg/dl (&lt;5.5– 6.7 mmol/L) </p> <p>all patients randomized to treatment with rosiglitazone received a starting oral dose of 4 mg once daily for 6 weeks; if the FPG value was &gt;100 mg/dl (&gt;5.5 mmol/L) after 6 weeks, rosiglitazone was increased to a maximum of 8 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> not stated (HbA1c differences between therapies) <br> SECONDARY OUTCOMES: <br> (not stated) <br> assessment of hypoglycaemia profile; changes in FPG, body weight, and serum lipids; proportion of patients achieving HbAA1C &lt;= 7%; cost of therapy </p> <p>safety was assessed in the intent to treat (ITT) population through adverse events, hypoglycaemia, body weight, physical examinations, vital signs, standard hematology,and blood chemistry </p> <p>a physical examination to identify signs of peripheral oedema was performed at baseline and final visit or at patient discontinuation </p> <p>Cost analysis: <br> The economic costs of glyceemic control were compared by combining selected measures of resource use with unit‐cost estimates. Resource measures included study medication, other antihyperglycaemic agents, syringes for insulin glargine, <br> glucose testing supplies for both groups, and recommended liver function tests for the rosiglitazone group. Resource use was <br> based on trial data over the 24‐week period. Costs of medications, insulin syringes, test strips, and lancets were <br> estimated using average wholesale prices expressed in 2002 U.S. dollars and were based on the numbers actually dispensed. The cost of hepatic function panels was estimated using fee schedules under Medicare’s Resource‐Based Relative Value Scale. Economic costs were summarized using means and 95% CIs and calculated through techniques of bootstrapping. Results were not adjusted for differences between treatment </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to evaluate the efficacy and safety of insulin glargine or rosiglitazone as add‐on therapy in patients with type 2 diabetes with chronic hyperglycemic control despite maximized combination therapy with metformin plus a sulfonylurea </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Stocker 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 24 weeks <br> DURATION OF FOLLOW‐UP: <br> 24 weeks <br> RUN‐IN PERIOD: <br> none <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> type 2 diabetes patients with suboptimally controlled diabetes mellitus <br> INCLUSION CRITERIA: <br> between 21 and 80 years of age, with a glycosylated hemoglobin level above 7.0% during treatment with either diet modification or sulfonylurea monotherapy <br> EXCLUSION CRITERIA: <br> known inflammatory diseases (including inflammatory bowel disease, vasculitis, and rheumatologic <br> disease), insulin use, corticosteroid use, an infection within 1 month of enrollment, glomerular filtration rate &lt; 60 ml/min, <br> pregnancy, known history of myocardial infarction or congestive heart failure, secondary diabetes (including Cushing’s syndrome and acromegaly), hypersensitivity to metformin or rosiglitazone, or a history of carotid endarterectomy DIAGNOSTIC CRITERIA: <br> not stated <br> CO‐MORBIDITIES: <br> known cardiovascular disease [no (%)] <br> I1: 2 (4.4%) <br> C1: 3 (6.4%) <br> CO‐MEDICATIONS: <br> statin use [no (%)]: <br> I1: 24 (53.3%) <br> C1: 23 (48.9%) <br> aspirin use [no (%)] : <br> I1: 21 (46.7%) <br> C1: 28 (59.6%) <br> beta‐blocker use [no (%)]: <br> I1: 8 (17.8%) <br> C1: 7 (14.9%) <br> calcium‐channel <br> blocker use [no (%)]: <br> I1: 6 (13.3%) <br> C1: 13 (27.7%) <br> angiotensin receptor <br> blocker use [no (%)]: <br> I1: 2 (4.4%) <br> C1: 0 (0%) <br> ACE inhibitor use [no (%)]: <br> I1: 23 (51.1%) <br> C1: 30 (63.8%) <br> sulfonylurea use [no (%)]: <br> I1: 34 (75.6%) <br> C1: 34 (72.3%) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 1 <br> COUNTRY/ LOCATION: <br> USA <br> SETTING: <br> Diabetes Institute of theWalter Reed Army Medical Center, Washington DC, USA <br> INTERVENTION (DOSE/DAY): <br> rosiglitazone 4 mg o.d. <br> CONTROL (DOSE/DAY): <br> metformin 850 mg b.i.d. <br> TREATMENT BEFORE STUDY: <br> diet modification or sulfonylurea monotherapy <br> TITRATION PERIOD: <br> other concurrent therapies (sulfonylurea, antihypertensive, or <br> statin medications) were continued at stable doses during the study </p> <p>nutrition counseling and diabetes education was offered to all participants at enrollment, in addition to their study medication </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> change in C‐reactive protein (CRP) levels after 24 weeks between the metformin and rosiglitazone treatment groups <br> SECONDARY OUTCOMES: <br> the predefined secondary <br> end point was the change in mean and maximal CIMT of the common carotid artery </p> <p>further outcomes: <br> FPG, HbA1c, lipids, weight, carotid intima media thickness (CIMT) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to compare the effects of rosiglitazone and metformin on C‐reactive <br> protein (CRP) and carotid intima media thickness (CIMT) </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Sutton 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 52 weeks <br> DURATION OF FOLLOW‐UP: <br> 52 weeks <br> RUN‐IN PERIOD: <br> 4‐week placebo run‐in period (single‐blind, with diet maintenance) <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> type 2 diabetic patients <br> INCLUSION CRITERIA: <br> patients aged 40–80 years were eligible if they met the NDDG definition forvtype 2 diabetes, with endogenous insulin production (fasting C‐peptide concentration &gt;= 0.8 ng/ml at screening); female patients had to be postmenopausal, surgically sterile, or currently using hormonal contraceptives or intrauterine devices <br> EXCLUSION CRITERIA: <br> clinically significant renal disease (serum creatinine level &gt;= 1.8 mg/dl) or hepatic disease (alanine transaminase, aspartate transaminase, total bilirubin, or alkaline phosphatase levels &gt; 2.5 times the upper limit of the normal laboratory range); previous treatment for myocardial infarction; NYHA class III‐IV, coronary insufficiency or congestive heart failure; previous or existing treatment with ACE inhibitors, angiotensin II receptor antagonists, beta‐blockers, or calcium‐channel blockers; echocardiographic evidence of marked left ventricular hypertrophy at baseline; or uncontrolled BP (&gt;160/&gt;100 mmHg); whereas patients taking diuretics and lipid‐lowering agents were not excluded from the study, doses were not to be changed during the study unless deemed medically appropriate <br> DIAGNOSTIC CRITERIA: <br> NDDG <br> CO‐MORBIDITIES: <br> concomitant hypertension (%) ‐ I: 7.7, C: 7.0 <br> CO‐MEDICATIONS: <br> not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 19 <br> COUNTRY/ LOCATION: <br> USA <br> SETTING: <br> not stated <br> INTERVENTION (DOSE/DAY): <br> rosiglitazone 8 mg (4 mg b.i.d.) <br> CONTROL (DOSE/DAY): <br> glyburide <br> TREATMENT BEFORE STUDY: <br> previous antidiabetic treatment : <br> diet only (%) ‐ I: 21.2, C: 18.2 <br> single agent (%) ‐ I: 70.2, C: 69.7 <br> combination therapy (%): I: 8.7, C: 12.1 </p> <p>2‐week screening period; previous oral antidiabetic medications were discontinued at the screening visit, at which time all patients received placebo and dietary instruction; patients were reevaluated at 2‐week intervals during the placebo run‐in period; those with FPG &gt;= 140 mg/dl but &lt;= 300 mg/dl at visits 2 and 3 were eligible to enter the treatment period <br> TITRATION PERIOD: <br> glyburide (q.i.d. or b.i.d.) was titrated at the discretion of the investigator to optimal glycemic effect over the first 8 weeks and then held constant for the duration of the study period; the dose of glyburide did not exceed 20 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> change from baseline in left ventricular mass index, at weeks 28 and 52, with the between‐groups difference as the primary comparison of interest <br> SECONDARY OUTCOMES: <br> (not stated) <br> changes from baseline to weeks 28 and 52 in left ventricular end‐diastolic volume and ejection fraction as well as mean values of BP, heart rate, arterial pressure, and pulse pressure (from 24‐h ambulatory monitoring); glycemic control (HbA1c and FPG); serum lipids fasting clinical laboratory tests, including chemistry, haematology, and urinalysis </p> <p>clinical interpretation of safety was based on review of ECG and echocardiographic data, adverse event reports, and laboratory values </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to assess the effect of long‐term rosiglitazone treatment on cardiac structure/function and glycaemic control in patients with type 2 diabetes compared with glyburide </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Yang 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 6 months <br> DURATION OF FOLLOW‐UP: <br> 6 months <br> RUN‐IN PERIOD: <br> single‐blind placebo/sulfonylurea run‐in period for 4 weeks to establish baseline characteristics <br> LANGUAGE OF PUBLICATION: <br> English </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> type 2 diabetic patients on concurrent sulphonylurea therapy <br> INCLUSION CRITERIA: <br> aged 30–80 years; type 2 diabetic patients according to diagnostic criteria of the WHO, FPG 7–15 mmol/L and HbA1c &gt; 7.5%; who had been stable on sulfonylurea therapy for at least 2 months before the screening <br> EXCLUSION CRITERIA: <br> other severe medical problems and severe microvascular complications requiring immediate medical attention <br> DIAGNOSTIC CRITERIA: <br> WHO <br> CO‐MORBIDITIES: <br> not stated <br> CO‐MEDICATIONS: <br> not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> not stated (1) <br> COUNTRY/ LOCATION: <br> Taiwan <br> SETTING: <br> not stated <br> INTERVENTION (DOSE/DAY): <br> rosiglitazone 4 mg/day (2mg b.i.d.) + sulfonylureas <br> CONTROL (DOSE/DAY): <br> placebo (twice daily) + sulfonylureas <br> TREATMENT BEFORE STUDY: <br> who had been stable on sulfonylurea therapy for at least 2 months before the screening <br> TITRATION PERIOD: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOMES: <br> not stated (plasma levels of adiponectin) <br> SECONDARY OUTCOMES: <br> (not stated) <br> HbA1c; body weight, height, blood pressure, heart rate, plasma glucose, total cholesterol, triglycerides, HOMA </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>AIM OF STUDY: <br> to assess whether adiponectin levels might increase in type 2 diabetes patients treated with rosiglitazone </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACE = angiotensin converting enzyme; ADA = American Diabetes Association; ALT = alanine aminotransferase; AST = aspartate aminotransferase; AT II = angiotensin II; b.(i.)d. = bis in die, twice daily; BMI = body mass index (kg/m2); BP = blood pressure; C = control group; CRP = C‐reactive protein; CVD = cardiovascular disease; ECG = electrocardiogram; FCBG = fasting capillary blood glucose; FPG = fasting plasma glucose; HbA1c = glycosylated haemoglobin A1c; HOMA = homeostasis model assessment (of insulin sensitvity); I = intervention group; ITT = intention‐to‐treat; NDDG = National Diabetes Data Group; NYHA = New York Heart Association; OAD = oral antidiabetic drug: OAM = oral antidiabetic medication; o.d. = once daily; PPAR = peroxisome proliferator activated receptor; PPG = postprandial glucose; q.d. = quaque die, once a day; SU = sulfonylureas; t.i.d. = ter in die, three times daily; TZD = thiazolidinediones ("glitazones"); U = Unit; WHO = World Health Organization </p> </div> </div> </p> </section> <section class="characteristicsOfExcludedStudies" lang=""> <div class="section-header" id="CD006063-sec2-0034"> <h3 class="title">Characteristics of excluded studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006063-sec2-0033" class="jump-to">included studies</a></li> <li><a href="#CD006063-sec2-0035" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reason for exclusion</p> </td> </tr> </thead> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0019">Bailey 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus metformin versus metformin)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0020">Baksi 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus gliclazide versus gliclazide)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0021">Barnett 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus sulfonylureas versus sulfonylureas plus placebo) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0022">Dailey 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus glyburide/metformin versus placebo plus glyburide/metformin) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0023">Fonseca 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus metformin versus placebo plus metformin) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0024">Fonseca 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus placebo versus rosiglitazone plus nateglinide) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0025">Gomez‐Perez 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus metformin versus placebo plus metformin) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0026">Hubacek 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>rosiglitazone treatment less than 24 weeks</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0027">Kerenyi 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus glibenclamide versus glibenclamide)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0028">McCluskey 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus glimepiride versus glimepiride)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0029">Negro 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus metformin versus placebo plus metformin) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0030">Raskin 2001</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus insulin versus placebo plus insulin) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0031">Reynolds 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus insulin plus life‐style modification versus placebo plus insulin plus life‐style modification) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0032">Rosenstock 2006a</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus glipizide versus placebo plus glipizide) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0033">Tan 2005a</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>rosiglitazone treatment less than 24 weeks</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0034">Tan 2005b</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>rosiglitazone treatment less than 24 weeks</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0035">Vongthavaravat 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus sulfonylureas versus sulfonylureas alone) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0036">Wang 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone versus "control" without treatment)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0037">Weissman 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus metformin versus metformin)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0038">Wolffenbuttel 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus sulfonylureas versus sulfonylureas plus placebo) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0039">Wong 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus insulin versus insulin)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006063-bbs2-0040">Zhu 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>treatment regimens not comparable (rosiglitazone plus sulfonylureas versus sulfonylureas plus placebo) </p> </td> </tr> </tbody> </table> </div> </p> </section> <section class="characteristicsOfOngoingStudies" lang=""> <div class="section-header" id="CD006063-sec2-0035"> <h3 class="title">Characteristics of ongoing studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006063-sec2-0033" class="jump-to">included studies</a></li> <li><a href="#CD006063-sec2-0034" class="jump-to">excluded studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">RECORD </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RECORD is a 6‐year, randomised, open‐label study in <br> type 2 diabetic patients with inadequate blood glucose control (HbA1c 7.1‐9.0%) on metformin or sulphonylurea alone. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>after a 4‐week run‐in, participants are randomised by current treatment stratum to <br> add‐on rosiglitazone, metformin or sulphonylurea, with <br> dose titration to a target HbA1c of &lt;=7.0%; if confirmed HbA1c rises to &gt;= 8.5%, either a third glucose‐lowering drug <br> is added (rosiglitazone‐treated group) or insulin is started <br> (non‐rosiglitazone group); the same criterion for failure of triple oral drug therapy in the rosiglitazone‐treated group is used for starting insulin in this group </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>the primary endpoint is the time to first cardiovascular hospitalisation or death, blindly adjudicated by a central endpoints committee; the <br> study aim is to evaluate non‐inferiority of the rosiglitazone <br> group versus the non‐rosiglitazone group with respect to cardiovascular outcomes; safety, tolerability and study conduct are monitored by an independent board </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>recruitment began in April 2001 and was completed in April 2003</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>P. D. Home <br> School of Clinical Medical Sciences‐Diabetes, <br> University of Newcastle upon Tyne, <br> Medical School, Framlington Place, <br> Newcastle upon Tyne, <br> NE2 4HH, UK </p> <p>E‐mail: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="eb9b838287829bc58384868eab858e9c888a989f878ec58a88c59e80">[email&#160;protected]</a> <br> Tel.: +44‐191‐2227019 <br> Fax: +44‐191‐2220723 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>study design and protocol published in Diabetologia 2005;48: 1726–35</p> </td> </tr> </tbody> </table> </div> </p> </section> </section> <section class="dataAndAnalyses" id="dataAndAnalyses"> <section class="dataAndAnalyses" lang="en"> <div class="section-header section-collapse-header" id="CD006063-sec1-0010"> <h2 class="title section-collapse-title">Data and analyses<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <div class="table" id="CD006063-tbl-0001"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Adverse events</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 No. of patients experiencing oedema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4739</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.27 [1.83, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006063-fig-00101"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006063.pub2/ppt/CDSR/CD006063/image_n/nCD006063-CMP-001-01.png?filename=nCD006063-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Adverse%20events%2C%20Outcome%201%20No.%20of%20patients%20experiencing%20oedema.&amp;citation=Richter B, Bandeira%E2%80%90Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Rosiglitazone for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2007, 3. Art. No.: CD006063. DOI: http://dx.doi.org/10.1002/14651858.CD006063.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.1</div> </div> <hr class="top"><img data-id="CD006063-fig-00101" src="/cdsr/doi/10.1002/14651858.CD006063.pub2/media/CDSR/CD006063/image_n/nCD006063-CMP-001-01.png" alt="Comparison 1 Adverse events, Outcome 1 No. of patients experiencing oedema."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Adverse events, Outcome 1 No. of patients experiencing oedema.</p> </div> </div> </div> </td> </tr> </tbody> </table> </div> </section> </section> <div class="figures-list"> <div class="figure" id="CD006063-fig-0001"> <img data-id="CD006063-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006063.pub2/media/CDSR/CD006063/image_n/nCD006063-AFig-FIG01.png" alt="QUOROM (quality of reporting of meta‐analyses) flow‐chart of study selection"> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>QUOROM (quality of reporting of meta‐analyses) flow‐chart of study selection</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/full#CD006063-fig-0001" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006063.pub2/ppt/CDSR/CD006063/image_n/nCD006063-AFig-FIG01.png?filename=nCD006063-AFig-FIG01.ppt&amp;title=1&amp;caption=QUOROM%20%28quality%20of%20reporting%20of%20meta%E2%80%90analyses%29%20flow%E2%80%90chart%20of%20study%20selection&amp;citation=Richter B, Bandeira%E2%80%90Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Rosiglitazone for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2007, 3. Art. No.: CD006063. DOI: http://dx.doi.org/10.1002/14651858.CD006063.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006063.pub2/media/CDSR/CD006063/image_n/nCD006063-AFig-FIG01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006063-fig-00101"><img data-id="CD006063-fig-00101" src="/cdsr/doi/10.1002/14651858.CD006063.pub2/media/CDSR/CD006063/image_n/nCD006063-CMP-001-01.png" alt="Comparison 1 Adverse events, Outcome 1 No. of patients experiencing oedema."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Adverse events, Outcome 1 No. of patients experiencing oedema.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/references#CD006063-fig-00101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006063.pub2/ppt/CDSR/CD006063/image_n/nCD006063-CMP-001-01.png?filename=nCD006063-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Adverse%20events%2C%20Outcome%201%20No.%20of%20patients%20experiencing%20oedema.&amp;citation=Richter B, Bandeira%E2%80%90Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Rosiglitazone for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2007, 3. Art. No.: CD006063. DOI: http://dx.doi.org/10.1002/14651858.CD006063.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006063.pub2/media/CDSR/CD006063/image_n/nCD006063-CMP-001-01.png">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD006063-tbl-0001" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Adverse events</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 No. of patients experiencing oedema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4739</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.27 [1.83, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Adverse events</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006063.pub2/references#CD006063-tbl-0001" class="tableList">Navigate to table in Review</a></div> </div> </div> <section class="translation-notes-modal" style="display: none" data-modal-title="Translation notes" data-modal-class="translation-notes" data-ok-btn-selector=".ok-btn"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="ja#CD006063-note-1201">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD006063-note-1204">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh#CD006063-note-1205">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" id="citeProcText" data-load-error="Unable to load citation data"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a href="#" class="addthis_button_citeulike at300b btn btn-link">CiteULike</a></li> <li><a href="#" class="addthis_button_mendeley at300b btn btn-link">Mendeley</a></li> <li><a href="#" class="citation-btn-refworks at300b btn btn-link" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <h4>Copy or download citation</h4> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button type="button" class="btn btn-link">Plain text</button></li> <li class="citation-option" data-option="endnote"><button type="button" class="btn btn-link">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button type="button" class="btn btn-link">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button type="button" class="btn btn-link">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button type="button" class="btn btn-link">BibteX</button></li> </nav> <div class="citation-content"> <pre id="citationContent" tabindex="0" data-load-error="Unable to load citation data"></pre> </div> <div class="clearfix"> <form class="download-citation-form" method="GET" target="citation-download-iframe" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=citation-citeproc&p_p_cacheability=cacheLevelPage&p_p_col_id=column-1&p_p_col_count=1"> <input type="hidden" id="siteId" name="siteId" value="" /> <input type="hidden" id="downloadType" name="downloadType" value="" /> <input type="hidden" id="style" name="style" value="" /> <input type="hidden" id="articleId" name="articleId" value="" /> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay" /><input name="p_p_lifecycle" type="hidden" value="2" /><input name="p_p_state" type="hidden" value="normal" /><input name="p_p_mode" type="hidden" value="view" /><input name="p_p_resource_id" type="hidden" value="citation-download" /><input name="p_p_cacheability" type="hidden" value="cacheLevelPage" /><input name="p_p_col_id" type="hidden" value="column-1" /><input name="p_p_col_count" type="hidden" value="1" /> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withAbstract"> <input class="checkbox" type="checkbox" name="withAbstract" /> <span class="checkbox-label">Include abstract</span> </label> </div> </form> <iframe title="Citation download frame" name="citation-download-iframe" src="" style="display: none; visibility: hidden" aria-hidden="true"></iframe> </div> </div> </div> </div> <div class="print-modal" style="display: none;" data-modal-title="Print this review"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input title="Select/deselect all" type="checkbox" class="print-options-select-all" checked="checked" /> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i class="fa fa-print" aria-hidden="true"></i> Print</button> </div> </div> <div class="download-stats-data-modal" style="display: none;" data-modal-title="Download statistical data"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <p> Downloaded data can only be viewed using <a class="external" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/tools/review-production-tools/revman-5" target="_blank">Review Manager software.</a> </p> <p> Please note that: <ul> <li>data are only available for Cochrane Reviews that contain one or more forest plots; and</li> <li>data in the downloaded RevMan file are editable and therefore the review data can be amended without warning.</li> </ul> </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input type="hidden" name="content-disposition" value="attachment" /> <input type="hidden" name="mime-type" value="application/octet-stream" /> <p class="print-options-controls"> <input type="checkbox" class="download-stats-data-toc-check-box" aria-label="I agree to these terms and conditions" /> <span class="checkbox-label" aria-hidden="true">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i class="fa fa-download" aria-hidden="true"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" style="display:none;" data-modal-title="Share this review"> <div class="add-this"> <div class="addthis_toolbox addthis_default_style addthis_32x32_style"> <nav class="stacked-nav-list"> <li> <a href="#" class="addthis_button_twitter at300b" title="Tweet">Twitter</a> </li> <li> <a href="#" class="addthis_button_mendeley at300b" target="_blank" title="Mendeley">Mendeley</a> </li> <li> <a href="#" class="addthis_button_facebook at300b" title="Facebook">Facebook</a> </li> <li> <a href="#" class="addthis_button_linkedin at300b" target="_blank" title="LinkedIn">LinkedIn</a> </li> <li> <a href="#" class="addthis_button_email at300b" target="_blank" title="Email">Email</a> </li> <li> <a href="#" class="addthis_button_whatsapp at300b" target="_blank" title="WhatsApp">WhatsApp</a> </li> <li class="clearfix"> <a href="#" class="addthis_button_more btn primary pull-right" target="_blank" title="View more"> <i class="fa fa-plus" aria-hidden="true"></i> View more</a> </li> </ul> </div> </div> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button type="button" class="btn btn-link" id="figureOptionBtn">Figures</button></li> <li class="table-options-btn-container"><button type="button" class="btn btn-link" id="tableOptionBtn">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div id="figureThumbnails" class="figure-thumbnails is-visible"></div> <div id="tableThumbnails" class="table-thumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a href="#" class="figure-viewer-menu-toggle"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-table-show-text="Show table list" data-table-hide-text="Hide table list" data-figure-show-text="Show thumbnails" data-figure-hide-text="Hide thumbnails">Hide thumbnails</span> </a> <a href="#" class="figure-viewer-zoomin"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a href="#" class="figure-viewer-zoomout"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a href="#" class="figure-viewer-nav previous"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a href="#" class="figure-viewer-nav next"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_  portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a title="Cochrane logo" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/">
<img class="footer-logo logo-part-1" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-1.png" alt="Cochrane logo" /> <img class="footer-logo logo-part-2" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-2.png" alt="" /> </a> </div> <nav class="footer-links"> <ul class="root"> <li class="footer-item"> <a class="footer-item-link" href="/about-cochrane1">About Cochrane</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/evidence" target="_blank">Cochrane.org</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank">Who we are</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NJYXT5SPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Get involved</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX665WNWTYE63PMNYXG4DTMFYGKLUQPJUB/" target="_blank">Consumer Network</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-funders-and-partners" target="_blank">Partners</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYXZ5DQPF4XT7LNF3SX8Z5IPJRX63JPN73GH/" target="_blank">Colloquium</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news" target="_blank">In the news</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/publications">Publications</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="/library">Cochrane Library</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/" target="_blank">Library Homepage</a> </li> <li class="footer-item"> <a class="footer-item-link" href="cdsr/about-cdsr" target="_blank">Cochrane Reviews (CDSR)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/central" target="_blank">Trials (CENTRAL)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cca/about" target="_blank">Cochrane Clinical Answers</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/cochrane-library-app" target="_blank">Cochrane Library App</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cdsr/journal-club" target="_blank">Journal Club</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/podcasts" target="_blank">Podcasts</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/community">Community</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Community</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MF3GG4DJMVYGG55DNB3GC5UFF3YYE3D/" target="_blank">Archie log-in</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/PS3GC4LPNFYGPLUDN7SXR6UBN3TT655TMH/" target="_blank">Training and support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/NWTYI4DQMS3T6Z5QMNVHEZLPMVYG86UH/" target="_blank">Methods</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/help" target="_blank">Software</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news/jobs" target="_blank">Jobs and opportunities</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/contact-us">Contact Us</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/contact" target="_blank">General enquiries</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/help/contact-us" target="_blank">Cochrane Library support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/chief-executive-officers-office/team" target="_blank">Chief Executive Officer</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/editorial-methods/team" target="_blank">Editor in Chief</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-global-community" target="_blank">Cochrane groups</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/media" target="_blank">Media</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/accessibility" target="_blank">Accessibility</a> </li> </ul> </li> </ul> </nav> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/advertisers">Advertisers & Agents</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Help & Support</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/terms-and-conditions">Terms & Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright &copy; 2000 - 2020 by <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUYNFXGK8JPMNYXN/" class="">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br /> Review our <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUYNFXGK8JPMNYXN/en-gb/privacy"><strong>Privacy Policy</strong></a> </p> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MW4T675JNSTYTLUDN7XB/"><img class="logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_wiley-footer-logo.png" alt="Wiley logo" /></a> </div> </div> <span class="wiley-semi-circle"></span> </div> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" style="display: none" data-modal-title="Feature in English only" data-modal-class="english-only-modal"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script src="/cochrane-theme/vendor/ie9.js?t=1581423095000" type="text/javascript"></script> <!--<![endif]--> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/theme.js?t=1581423095000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/checkout.js"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MN3G865UNWRYE43NMNTG6LUDPJYYG65TMWUC655TMH/widget/v2.0/widget.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MRZXE8DIHB4XC63SNWYHPN3PMNXG87LEM33G85UVF3YGK7A/assets/embed.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717777000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717709000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717714000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006063\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006063\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006063\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006063\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006063\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581423095000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a href="#" class="rh-nav-close-btn"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a href="#" class="rh-nav-open-btn"> <span>Review tools & navigation</span> </a> </div> <iframe title="Print frame" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <div class="mobile-navigation"> <div class="close-container"> <a href="#" class="main-nav-back-btn" aria-label="Navigate back"><i class="fa fa-chevron-left"></i></a> <a href="#" class="main-nav-close-btn" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="ymag__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006063.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006063.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<a href="/en/browse-by-topic" class="btn secondary">Browse </a>
<a href="/en/advanced-search" class="btn secondary advanced-search-button">Advanced search</a>
</div>
<div class="menu-items parent">
<ul>
<li class="nav-root-item parent">
<a href="#" title="Select language" class="language-selection-title-link">
<span class="mobile-nav-language-title">Select your preferred language</span><span class="icon fa fa-caret-down"></span>
<ul class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="fdkn__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div id="active-content-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div id="active-portal-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="/en/cdsr/doi/10.1002/14651858.CD006063.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD006063.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</ul>
</a>
</li>
<li class="parent">
<a class="mobile-link signin" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006063.pub2%2Freferences" data-redirect="false" rel="nofollow">
Sign In
</a>
</li>
</ul>
<div class="menu-items-footer">
<div class="utility-links">
<a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/" class="cochrane-link" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
<div class="basic-login-form-content" style="display: none;" data-modal-title="Sign in">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="dbam__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1583239516407" /> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value="" /> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true" /> <input checked class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onClick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true" /> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user-registration" target="_blank" class="btn secondary">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" style="display: none;" data-modal-title="Institutional login">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="obft__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text">
</div>
<button class="btn primary" type="submit" name="button">Go</button>
</div>
<div id="institutionLookupErrorDiv" class="message error" style="display:none">
'<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
</div>
</div>
<input type="hidden" id="entityId" name="entityId" value="">
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="joiu__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1583239516411" /> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006063&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value="" /> </div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true" /> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" style="display: none;" data-modal-title="Unlock the potential of Cochrane evidence">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="wpdq__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text"> </div> <button class="btn primary" type="submit" name="button">Go</button> </div> <div id="institutionLookupErrorDiv" class="message error" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input type="hidden" id="entityId" name="entityId" value=""> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'> <input type="hidden" name="openlabel" id="openlabel" value='Open access'> </div> </section> </div> </div>  <script>window.urlTitle="/cdsr/doi/10.1002/14651858.CD006063.pub2";addthis_config={pubid:"ra-593597d01cdf9a55",ui_508_compliant:true};addthis_share={url:window.location.href,title:document.title};</script> <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-593597d01cdf9a55"></script> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> </body> </html> 